false 2024 FY 0001869601

 CIK0001869601:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneWarrantMember

 CIK0001869601:OrdinarySharesMember

 us-gaap: RightsMember

 CIK0001869601:WarrantsMember

 2024-06-30

 2025-03-11

 2023-01-01

 2023-01-01

 2023-01-01

 2023-01-01

 us-gaap: IPOMember

 us-gaap: OverAllotmentOptionMember

 us-gaap: IPOMember

 us-gaap: IPOMember

 us-gaap: PrivatePlacementMember

 CIK0001869601:USGovernmentSecuritiesMember

 2023-08-01
 2023-08-09

 CIK0001869601:PublicShareMember

 2023-08-09

 2023-08-01
 2023-08-14

 2023-08-14

 2023-10-01
 2023-10-20

 2023-10-20

 2024-08-01
 2024-08-12

 2024-09-02
 2024-09-10

 2022-01-01

 CIK0001869601:ConvertibleNoteMember

 us-gaap: OverAllotmentOptionMember

 2023-08-01
 2023-08-09

 2023-08-07

 2024-08-12

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 CIK0001869601:PublicWarrantsMember
 us-gaap: CommonClassAMember

 CIK0001869601:PrivatePlacementWarrantsMember

 2021-01-01
 2021-12-31

 2022-06-25
 2022-07-01

 2022-07-01

 us-gaap: OverAllotmentOptionMember

 2021-01-01
 2021-12-31

 CIK0001869601:ProposedOfferingMember

 2022-06-25
 2022-07-01

 CIK0001869601:FirstConvertiblePromissoryNoteMember

 2023-09-08

 2023-10-31

 2023-11-30

 CIK0001869601:ZhengYuanMember

 2023-09-30

 CIK0001869601:CFOMember

 CIK0001869601:CFOMember

 CIK0001869601:CFOMember

 CIK0001869601:CFOMember

 CIK0001869601:WorkingCapitalLoanMember

 CIK0001869601:UnrelatedThirdPartyMember

 2024-08-05

 2024-08-02
 2024-08-05

 2024-08-03
 2024-08-06

 CIK0001869601:ProposedOfferingMember

 2021-10-01
 2021-10-24

 2021-10-01
 2021-10-24

 CIK0001869601:OrdinarySharesMember

 CIK0001869601:OrdinarySharesMember

 CIK0001869601:RedemptionOfWarrantsMember
 CIK0001869601:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember
 us-gaap: CommonClassAMember

 CIK0001869601:RedemptionOfWarrantsMember
 CIK0001869601:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember
 us-gaap: CommonClassAMember

 CIK0001869601:SharePriceEqualOrExceedsEighteenRupeesPerDollarMember
 us-gaap: CommonClassAMember

 us-gaap: IPOMember

 CIK0001869601:PublicWarrantsMember

 CIK0001869601:PrivatePlacementWarrantsMember

 2025-03-31

 UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 FORM 10-K

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended December 31, 2024

 or

 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from ________ to ________

 Commission file number: 001-41397

 (Exact name of registrant as specified in its charter)

 Cayman Islands

 N/A 00-0000000

 (State or other jurisdiction of

 incorporation or organization)

 (I.R.S. Employer

 Identification No.)

 5186 Carroll Canyon Rd

 San Diego, CA 92121

 92121

 (Address of principal executive offices)

 (Zip Code)

 Registrant's telephone number, including
area code: (858) 688-4965

 Securities registered pursuant to Section 12(b) of the Act:

 Title of Each Class

 Trading Symbol

 Name of Each Exchange on Which Registered

 Units, each consisting of one ordinary share, one right and one warrant

 EMCGU

 The Nasdaq Stock Market LLC

 Ordinary Shares

 EMCG

 The Nasdaq Stock Market LLC

 Rights

 EMCGR

 The Nasdaq Stock Market LLC

 Warrants

 EMCGW

 The Nasdaq Stock Market LLC

 Securities registered pursuant to Section 12(g) of the Act: None.

 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No

 Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging Growth Company

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes No

 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 As of June 30, 2024, the aggregate market value of the Registrant's ordinary shares held by non-affiliates of the Registrant was $ 57,681,923.

 As of March 11, 2025, there were 4,520,024 ordinary shares, par value $0.0001, of the Company issued and outstanding.

 DOCUMENTS INCORPORATED BY REFERENCE

 None.

 Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2024

 ITEM 1.

 BUSINESS

 ITEM 1A.

 RISK FACTORS

 ITEM 1B.

 UNRESOLVED STAFF COMMENTS

 ITEM 1C.

 CYBERSECURITY

 ITEM 2.

 PROPERTIES

 ITEM 3.

 LEGAL PROCEEDINGS

 ITEM 4.

 MINE SAFETY DISCLOSURES

 ITEM 5.

 MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 ITEM 6.

 [RESERVED]

 ITEM 7.

 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 ITEM 7A.

 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 ITEM 8.

 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 ITEM 9.

 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 ITEM 9A.

 CONTROLS AND PROCEDURES

 ITEM 9B.

 OTHER INFORMATION

 ITEM 9C.

 DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 ITEM 10.

 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 ITEM 11.

 EXECUTIVE COMPENSATION

 ITEM 12.

 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 ITEM 13.

 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 ITEM 14.

 PRINCIPAL ACCOUNTANT FEES AND SERVICES

 ITEM 15.

 EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 ITEM 16.

 FORM 10-K SUMMARY

 i

 FORWARD LOOKING STATEMENTS

 This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements contained in this report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipates," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this report may include, for example, statements about our:

 ability to complete our initial business combination;

 success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;

 officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;

 potential ability to obtain additional financing to complete our initial business combination;

 pool of prospective target businesses;

 the ability of our officers and directors to generate a number of potential investment opportunities;

 potential change in control if we acquire one or more target businesses for stock;

 the potential liquidity and trading of our securities;

 the lack of a market for our securities;

 use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or

 financial performance following our initial public offering.

 The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our other Securities and Exchange Commission ("SEC") filings. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws and/or if and when management knows or has a reasonable basis on which to conclude that previously disclosed projections are no longer reasonably attainable.

 ii

 ITEM 1.

 BUSINESS

 In this Annual Report on Form 10-K (the "Form 10-K"), references to the "Company" and to "we," "us," and "our" refer to Embrace Change Acquisition Corp.

 Introduction

 We are a blank check company incorporated as a Cayman Islands exempted company on March 3, 2021. Exempted companies are Cayman Islands companies wishing to conduct business outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption undertaking from the Cayman Islands government that, in accordance with section 6 of the Tax Concessions Act (2018 Revision) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.

 We were incorporated for the purpose of entering
into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination
with one or more businesses or entities, which we refer to as a "target business." Our efforts to identify a prospective
target business are limited to a particular industry or geographic location. As approved by our
shareholders at the annual general meeting on October 20, 2023, our second amended and restated memorandum and articles of
association of the Company (the "Amended Articles of Association"), as amended, no long restricts us to undertake an
initial business combination with any entity or business based in, or with its principal or a majority of its business operations
(either directly or through any subsidiaries) in, the People's Republic of China (including Hong Kong and Macau). Since many
of our officers and directors have business experience in China or reside in China, being able to target a business in China may
make it easier to find an attractive target business, and it may make us a more attractive partner to Hong Kong and People's
Republic of China targets. Because our offices are in the United States, we currently do not operate in China, and a majority of our
officers and directors are outside of China, we are not subject to Chinese regulations, such as those put out by the China
Securities Regulatory Commission or Cyberspace Administration of China. However, the relationships of our officers and directors to
China could influence the types of targets that they select to acquire due to changes in laws or regulations in China, which could
result in significantly reduced securities trading prices of a post-business combination company. Because we are based in the United
States and our auditor is based in the United States, we are not subject to the Holding Foreign Companies Accountable Act or related
regulations and our auditor is not subject to determinations announced by the PCAOB on December 16, 2021.

 On August 12, 2022, we consummated our initial public offering (the "IPO") of 7,392,855 units (the "Units"), including the issuance of 892,855 Units as a result of the partial exercise by EF Hutton LLC, formerly known as EF Hutton, division of Benchmark Investments, LLC (the "Representative" or "EF Hutton") of its over-allotment option (the "Over-Allotment Option"). Each Unit consists of one ordinary share, one warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described in the IPO prospectus. Each right entitles the holder thereof to acquire one-eighth of one ordinary share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $73,928,550.

 Simultaneously with the closing of the IPO on August 12, 2022, we consummated the private placement (the "Private Placement") with Wuren Fubao Inc., our sponsor, purchasing 373,750 units (the "Private Units") at a price of $10.00 per Private Unit, generating total proceeds of $3,737,500. The Private Units are identical to the Units sold in the IPO except that the holder has agreed not to transfer, assign, or sell any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until the completion of the Company's initial business combination. In addition, the warrants included in the Private Units are not redeemable if held by them or a permitted transferee. The sponsor was granted certain demand and piggy-back registration rights in connection with the purchase of the Private Units.

 Also simultaneously with the closing of the IPO, pursuant to the Underwriting Agreement, the Company issued an aggregate of 73,929 ordinary shares of the Company (the "Representative Shares") to the Representative, including 8,929 additional Representative Shares issued as a result of the Representative's partial exercise of its Over-Allotment Option. The Representative has agreed not to transfer, assign or sell any of the Representative Shares (except in limited circumstances, as described in the Underwriting Agreement) until the completion of the Company's initial business combination. No underwriting discounts or commissions were paid with respect to such sale.

 On August 12, 2022, a total of $75,776,764 of the net proceeds from the IPO and the Private Placement (including $72,039,264 of the net proceeds from the IPO (which amount includes $2,587,499 of the underwriters' deferred discount before it was revised by Satisfaction and Discharge Agreement entered on March 4, 2024) and $3,737,500 from the Private Placement), were placed in a trust account established for the benefit of our public shareholders at JP Morgan Chase, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except as set forth below, the proceeds held in the trust account will not be released until the earlier of: (1) the completion of our initial business combination within the required time period; (2) our redemption of 100% of the outstanding public shares if we have not completed an initial business combination in the required time period; and (3) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption of public shares as described in the IPO prospectus or redeem 100% of our public shares if we do not complete our initial business combination within the required time period or (B) with respect to any other provision relating to shareholders' rights or pre-business combination activity. Therefore, unless and until our initial business combination is consummated, the proceeds held in the trust account will not be available for our use for any expenses which we may incur related to the investigation and selection of a target business and the negotiation of an agreement to acquire a target business.

 Notwithstanding the foregoing, there can be released to us from the trust account any interest earned on the funds in the trust account that we need to pay our income or other tax obligations. With this exception, expenses incurred by us may be paid prior to an initial business combination only from the net proceeds of the IPO not held in the trust account of approximately $500,000; provided, however, that in order to meet our working capital needs following the consummation of the IPO if the funds not held in the trust account are insufficient, our initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our initial business combination, without interest, or, at the lender's discretion, up to $500,000 of the notes may be converted upon consummation of our initial business combination into additional private units at a price of $10.00 per unit upon conversion of such notes, to the extent the holder wishes to so convert them at the time of the consummation of our initial business combination. If we do not complete an initial business combination, the loans will only be repaid with funds not held in the trust account, and only to the extent available.

 Recent Developments

 Commencing on August 9, 2022, we have agreed
to pay ARC Group Limited, our sponsor's financial advisor, a total of $10,000 per month for utilities and secretarial
and administrative support. In October 2023, the Company and ARC Group Limited terminated the administrative support agreement.
For the year ended December 31, 2024, the Company has incurred such expenses of $50,000 and paid in full.

 On March 4, 2024, the Company and D. Boral Capital LLC ("D. Boral"), formerly known as EF Hutton, division of Benchmark Investments,
LLC, the underwriter of Embrace Change's initial public offering, entered into a Satisfaction and Discharge of Indebtedness Pursuant
to Underwriting Agreement dated August 9, 2022 (the "Satisfaction and Discharge Agreement"), pursuant to which, EF Hutton
agreed to revise the deferred underwriting fee of three point five percent (3.50%) of the gross proceeds of the initial public offering,
or $2,587,499, to (1) $750,000 in cash on the date of the closing of the initial business combination (the "Closing") and
(2) 200,000 of registered and unrestricted shares of the Company, shall be issued and delivered to EF Hutton at the Closing.

 On April 23, 2024, the Company received a delisting
determination letter from the Listing Qualifications of Nasdaq advising the Company that the Company has not paid its assessed fees required
by Listing Rule 5250(f). The Company subsequently paid the outstanding fee.

 On May 30, 2024, the Company received a delinquency
notification letter from Nasdaq due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company's
failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024.

 On June 24, 2024, the Company received a notice from
Nasdaq indicating that, unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the "Panel") by 4:00
p.m. Eastern Time on July 1, 2024, the Company's securities (units, ordinary shares, warrants, and rights) would be subject to suspension
and delisting from The Nasdaq Global Market at the opening of business on July 3, 2024, due to the Company's non-compliance with
the Minimum Holders Rule and the Reporting Rule. The Company timely requested a hearing before the Panel to appeal the Staff Determination
and submitted a request for extension of stay. The suspension referenced in the Staff Determination has been stayed for a period of 15
calendar days until July 16, 2024 and the hearing has been scheduled on August 1, 2024.

 On July 12, 2024, the Company submitted a written submission to Nasdaq.
On July 25, 2024, the Company received a notice from Nasdaq indicating the grant of the Company's request to extend the stay of
suspension pending a hearing on August 1, 2024, and issuance of a final Panel decision.

 On August 12, 2024, the Company held an extraordinary
general meeting of shareholders (the "Second Extraordinary General Meeting"), at which, the Company and its Trustee signed
an amendment to the Trust Agreement, to give the Company the right to extend the Combination Period twelve (12) times for an additional
one (1) month each time, from August 12, 2024 to August 12, 2025 (the "Extended Date"), by depositing into the Trust Account
$75,000 for each one-month extension (the "Amended Extension Payment"), as approved by the Company's shareholders in
accordance with the Company's Amended Articles of Association. At the Second Extraordinary General Meeting, the shareholders of
the Company approved a special resolution to the Amended Articles of Association to extend the Combination Period from the Termination
Date to the Extended Date and to delete words "(less up to US$50,000 of interest to pay dissolution expenses)".

 On October 30, 2024, the Company received a letter
from Nasdaq which confirmed that the Company regained compliance on September 16, 2024 with the filing requirement in Listing Rule 5250(c),
as required by the Nasdaq hearing panel's decision dated August 14, 2024. The Company is subject to a mandatory panel monitor for
a period of one year from September 16, 2024. Under the terms of the panel monitor, in the event the Company is again out of compliance
with the periodic filing rule during the monitoring period, the Company will have an opportunity to request a new hearing before the panel
in order to maintain its listing, rather than being granted additional time to regain compliance or being afforded an applicable cure
or compliance period.

 Merger Agreement

 On January 26, 2025, the Company entered into
a Merger Agreement (as it may be amended from time to time, the "Merger Agreement"), by and between the Company, EMC Merger
Sub 1, a Cayman Islands exempted company and wholly owned subsidiary of the Parent ("Purchaser"), EMC Merger Sub 2, a Cayman
Islands exempted company and wholly owned subsidiary of Purchaser ("Merger Sub"), and Tianji Tire Global (Cayman) Limited,
an exempted company incorporated under the laws of the Cayman Islands with limited liability ("Tianji"), which provides for
a Business Combination between Embrace Change and Tianji. Pursuant to the Merger Agreement, the Business Combination will be effected
in two steps: (i) subject to the approval and adoption of, among other things, the Reincorporation Merger and the Reincorporation Plan
of Merger by the shareholders of Embrace Change, Embrace Change will merge with and into Purchaser; and Purchaser
as the surviving corporation after Reincorporation Merger is hereinafter sometimes referred to as the "Reincorporation Merger Surviving
Corporation" with Reincorporation Merger Surviving Corporation remaining as the surviving publicly traded entity (the "Reincorporation
Merger"); (ii) promptly after the Reincorporation Merger, Merger Sub will be merged with and into Tianji, with Tianji remaining
as the surviving entity, resulting in Tianji being a wholly-owned subsidiary of Reincorporation Merger Surviving Corporation (the "Acquisition
Merger").

 Sponsor Support Agreement

 Contemporaneously with the execution of the Merger
Agreement, Sponsor entered into a support agreement with Embrace Change and Tianji (the "Sponsor Support Agreement"), pursuant
to which Sponsor agreed to, among other things, approve the Merger Agreement and the proposed Business Combination.

 The foregoing description of the Sponsor Support
Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the actual agreement, a copy
of which was filed as Exhibit 10.1 to the Current Report of Embrace Change on Form 8-K, filed with the SEC on January 27, 2025 and is
incorporated herein by reference.

 Company Support Agreement

 In connection with the execution of the Merger
Agreement, certain Tianji Shareholders entered into a support agreement with Embrace Change and Tianji (the "Company Support Agreement"),
pursuant to which such holders agreed to, among other things, approve the Merger Agreement and the proposed Business Combination.

 The foregoing description of the Company Support
Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the actual agreement, a copy
of which was filed as Exhibit 10.2 to the Current Report of Embrace Change on Form 8-K, filed with the SEC on January 27, 2025 and is
incorporated herein by reference.

 Additional Agreements to be Executed at Closing

 Lock-Up Agreements

 Upon the Closing, certain shareholders of Embrace
Change and shareholders of Tianji ("Holders") will execute lock-up agreements (the "Lock-up Agreements"). Pursuant
to the Lock-Up Agreements, these Holders will, subject to certain customary exceptions, agree not to (i) sell, contract to sell, pledge
or otherwise dispose of, directly or indirectly, Reincorporation Merger Surviving Corporation Class A Ordinary Shares held by them (the
"Lock-Up Shares"), (ii) enter into a transaction that would have the same effect, (iii) enter into any swap, hedge, or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Shares, whether
any of these transactions are to be settled by delivery of any such Lock-Up Shares, in cash or otherwise, or (iv) publicly disclose any
intention to effect any transaction specified in clauses (i) or (ii), until the date that is six (6) months after the date of the Closing
(the "Lock-Up Period").

 Registration Rights Agreement

 At the closing of the Business Combination, Reincorporation
Merger Surviving Corporation will enter into a registration rights agreement (the "Registration Rights Agreement") with Sponsor
and with certain shareholders of Tianji with respect to certain shares, units, private units (and the private shares and private warrants)
to the extent they own at the closing. The Registration Rights Agreement will provide certain demand registration rights and piggyback
registration rights to the shareholders, subject to underwriter cutbacks and issuer blackout periods. Reincorporation Merger Surviving
Corporation will agree to pay certain fees and expenses relating to registrations under the Registration Rights Agreement.

 The foregoing description of the Registration
Rights Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the actual agreement,
a form of which was filed as Exhibit 10.3 to the Current Report of Embrace Change on Form 8-K, filed with the SEC on January 27, 2025,
and is incorporated herein by reference.

 Competitive Advantage

 We have an experienced and highly professional management team, almost all of whom have entrepreneurial experience or experience working for public companies, and we believe that this valuable experience can help us to better identify outstanding companies that are considering becoming public companies.

 Our Chief Executive Officer Jingyu Wang served as an advisor to the Company in connection with its initial public offering and public disclosures from September 2021 until his appointment as Chief Executive Officer. From June 2015 to September 2021, Mr. Wang served as the secretary of the board for 36Kr Holdings Inc., a company listed on Nasdaq (Nasdaq: KRKR), for which he coordinated the Company's public disclosures, so we believe Mr. Wang's unique experience and contacts will help us identify great target companies.

 Our Chief Financial Officer, Zheng Yuan, has extensive financial management experience, having worked for several major Chinese banks. From October 2010 to March 2016, she was the Vice President of the International Banking Department of Bank of Beijing Corporation, responsible for international settlements, cooperation with international counterparts, and anti-money laundering operations. We believe that Ms. Zheng Yuan's extensive and long-term multinational financial management experience will help us to better identify the financial risks of potential investment targets and to find outstanding companies to acquire.

 In addition to rich experience in entrepreneurship
and management, our management team also has an international background. All of our team members have rich experience in the management
of large multinational enterprises and are familiar with the international markets. Given this broad experience, we believe that our
management team will be able to source international target opportunities to help us find the best possible target for our investors.
Their collective experience and expertise and ability to source a potential target is not limited by geographic region and therefore
management and our Board members will be considering a business combination target which could have operations anywhere in the world,
excluding China.

 Our independent director Mo Zhou is a Canadian citizen and is living and working in Canada, and has rich legal and SPAC experiences. Ms. Zheng Yuan, and our independent director, Mr. Hang Zhou, are from China and are living in the United States, and Ms. Zheng Yuan has extensive experience in multinational financial management. Mr. Hang Zhou has over 20 years of experience in developing new businesses and products in domestic and international markets. Our other independent director, Gary Xiao, has lived and worked in the United States and is an experienced independent director, audit committee chair and CFO with experience in IT and human resources management for both public and private companies.

 Investment Direction and Strategy

 If the Business Combination with Tianji does not
close, it is our intention to pursue prospective targets that are in the technology, internet, and consumer sectors, and we will look
for companies with established brands, stable cash flow, and readiness to access capital markets. In addition, we want to find companies
that are truly technology driven and have strong industry competencies.

 While we will give priority to companies in technology, internet, and consumer sectors, we will have no specific industry restriction, and we plan on exploring opportunities in enterprise services, artificial intelligence, culture and media, biotechnology, new consumer brands, blockchain and other areas that show the interest of investors.

 We plan to focus on the management team of potential target companies because we believe that only a mature and adaptable management team is the most reliable competitive edge in dealing with complex competitive environments, and because all good products and services are built by a good team.

 Investment Criteria

 If the Business Combination with Tianji does not
close, below is a list of criteria we will consider when evaluating target companies:

 We expect to focus on the management team of the potential target company, which we look to have strong entrepreneurial and management experience, excellent values, adaptability, and the ability to deal with a variety of complex situations, as well as a variety of potential challenges.

 We wanted to find a technology-driven company in an industry that has high barriers to entry and that would further be able to consolidate its strengths through a transaction with us.

 We expect these companies to have mature products and services that are already well accepted by the market and have positive cash flow or are close to achieving positive cash flow, rather than being in the early loss-making stages.

 We will look for a target company that has built a brand that customers trust and has significant influence.

 We will also look at the ESG (environmental, social, governance) efforts made by the company. We believe that a truly outstanding company should have a strong sense of social responsibility, in addition to an excellent management team and providing excellent products and services.

 Effecting Our Initial Business Combination

 General

 We are not presently engaged in, and we will not
engage in, any operations for an indefinite period of time. We intend to effectuate our initial business combination using cash from the
proceeds of the IPO and the private placement of the private units, our shares, new debt, or a combination of these, as the consideration
to be paid in our initial business combination. If the Business Combination with Tianji does not close, we may seek to consummate our
initial business combination with a company or business that may be financially unstable or in its early stages of development or growth,
which would subject us to the numerous risks inherent in such companies and businesses, although we will not be permitted to effectuate
our initial business combination with another blank check company or a similar company with nominal operations.

 If our initial business combination is paid for using shares or debt securities, or not all of the funds released from the trust account are used for payment of the purchase price in connection with our business combination or used for redemptions of purchases of our ordinary shares, we may apply the cash released to us from the trust account that is not applied to the purchase price for general corporate purposes, including for maintenance or expansion of operations of acquired businesses, the payment of principal or interest due on indebtedness incurred in consummating our initial business combination, to fund the purchase of other companies or for working capital.

 Subject to the requirement that our initial business combination must be with one or more target businesses or assets having an aggregate fair market value of at least 80% of the value of the trust account (less any revised deferred underwriting commissions and taxes payable on interest earned) at the time of the agreement to enter into such initial business combination, we have virtually unrestricted flexibility in identifying and selecting one or more prospective target businesses. Accordingly, there is no current basis for investors in the IPO to evaluate the possible merits or risks of the target business with which we may ultimately complete our initial business combination. Although our management will assess the risks inherent in a particular target business with which we may combine, this assessment may not result in our identifying all risks that a target business may encounter. Furthermore, some of those risks may be outside of our control, meaning that we can do nothing to control or reduce the chances that those risks will adversely impact a target business.

 We may seek to raise additional funds through a private offering of debt or equity securities in connection with the consummation of our initial business combination, and we may effectuate our initial business combination using the proceeds of such offering rather than using the amounts held in the trust account. Subject to compliance with applicable securities laws, we would consummate such financing only simultaneously with the consummation of our business combination. In the case of an initial business combination funded with assets other than the trust account assets, our tender offer documents or proxy materials disclosing the business combination would disclose the terms of the financing and, only if required by law or the rules of Nasdaq, we would seek shareholder approval of such financing. There are no prohibitions on our ability to raise funds privately or through loans in connection with our initial business combination. At this time, we are not a party to any arrangement or understanding with any third party with respect to raising any additional funds through the sale of securities or otherwise.

 Sources of Target Businesses

 If the Business Combination with Tianji does not
close, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment
bankers, venture capital funds, private equity funds, leveraged buyout funds, management buyout funds and other members of the financial
community. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us through
calls or mailings. These sources may also introduce us to target businesses they think we may be interested in on an unsolicited basis,
since many of these sources will have read our IPO prospectus and know what types of businesses we are targeting.

 Our officers and directors, as well as their respective affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. While we do not presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay a finder's fee, consulting fee or other compensation to be determined in an arm's length negotiation based on the terms of the transaction. In no event, however, will any of our existing officers, directors or initial shareholders, or any entity with which they are affiliated, be paid any finder's fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the consummation of a business combination (regardless of the type of transaction). Some of our officers and directors may enter into employment or consulting agreements with the post-transaction company following our initial business combination. The presence or absence of any such fees or arrangements will not be used as a criterion in our selection process of an initial business combination candidate.

 We are not prohibited from pursuing an initial business combination with a company that is affiliated with our initial shareholders, officers or directors. In the event we seek to complete our initial business combination with a target that is affiliated with our initial shareholders, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that our initial business combination is fair to our company (or shareholders) from a financial point of view.

 Selection of a Target Business and Structuring of Our Initial Business Combination

 Subject to the requirement that our initial business combination must be with one or more target businesses or assets having an aggregate fair market value of at least 80% of the value of the trust account (less any revised deferred underwriting commissions and taxes payable on interest earned) at the time of the agreement to enter into such initial business combination, our management will have virtually unrestricted flexibility in identifying and selecting one or more prospective target businesses, although we will not be permitted to effectuate our initial business combination with another blank check company or a similar company with nominal operations. In any case, we will only consummate an initial business combination in which we become the majority shareholder of the target (or control the target through contractual arrangements in limited circumstances for regulatory compliance purposes as discussed below) or are otherwise not required to register as an investment company under the Investment Company Act. There is no basis for investors in the IPO to evaluate the possible merits or risks of any target business with which we may ultimately complete our initial business combination. To the extent we effect our initial business combination with a company or business that may be financially unstable or in its early stages of development or growth, we may be affected by numerous risks inherent in such company or business. Although our management will endeavor to evaluate the risks inherent in a particular target business, we may not properly ascertain or assess all significant risk factors.

 In evaluating a prospective target business, we will conduct an extensive due diligence review which will encompass, among other things, meetings with incumbent management and inspection of facilities, as well as review of financial and other information which is made available to us. This due diligence review will be conducted either by our management or by unaffiliated third parties we may engage, although we have no current intention to engage any such third parties.

 The time and costs required to select and evaluate a target business and to structure and complete the business combination cannot presently be ascertained with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target business with which a business combination is not ultimately completed will result in a loss to us and reduce the amount of capital available to otherwise complete a business combination.

 Fair market value of target business or businesses

 Nasdaq rules provide that our initial business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the trust account (less any revised deferred underwriting commissions and taxes payable on interest earned) at the time of our signing a definitive agreement in connection with our initial business combination. If our board is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions with respect to the satisfaction of such criteria.

 We anticipate structuring our initial business combination to acquire 100% of the equity interest or assets of the target business or businesses. We may, however, structure our initial business combination to acquire less than 100% of such interests or assets of the target business, but we will only consummate such business combination if we will become the majority shareholder of the target (or control the target through contractual arrangements in limited circumstances for regulatory compliance purposes) or are otherwise not required to register as an "investment company" under the Investment Company Act. Even though we will own a majority interest in the target, our shareholders prior to the business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock, shares or other equity securities of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our issued and outstanding shares subsequent to our initial business combination.

 The fair market value of a target business or businesses or assets will be determined by our board of directors based upon standards generally accepted by the financial community, such as actual and potential gross margins, the values of comparable businesses, earnings and cash flow, book value and, where appropriate, upon the advice of appraisers or other professional consultants. If our board of directors is not able to independently determine that the target business or assets has a sufficient fair market value to meet the threshold criterion, we will obtain an opinion from an unaffiliated, independent investment banking firm or an independent accounting firm with respect to the satisfaction of such criterion. Notwithstanding the foregoing, unless we consummate a business combination with an affiliated entity, we are not required to obtain an opinion from an independent investment banking firm or an independent accounting firm that the price we are paying is fair to our shareholders.

 Lack of Business Diversification

 For an indefinite period of time after consummation of our initial business combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. By consummating our initial business combination with only a single entity, our lack of diversification may:

 subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and

 cause us to depend on the marketing and sale of a single product or limited number of products or services.

 Limited ability to evaluate the target's management team

 Although we intend to closely scrutinize the management of a prospective target business when evaluating the desirability of effecting our initial business combination with that business, our assessment of the target business' management may not prove to be correct. The future role of members of our management team, if any, in the target business cannot presently be stated with any certainty. Consequently, members of our management team may not become a part of the target's management team, and the future management may not have the necessary skills, qualifications or abilities to manage a public company. Further, it is also not certain whether one or more of our directors will remain associated in some capacity with us following our initial business combination. Moreover, members of our management team may not have significant experience or knowledge relating to the operations of the particular target business. Our key personnel may not remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel will remain with the combined company will be made at the time of our initial business combination.

 Following our initial business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We may not have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.

 Shareholders may not have the ability to approve our initial business combination

 In connection with any proposed business
combination, we will either (1) seek shareholder approval of our initial business combination at a general meeting called for such
purpose at which shareholders may seek to convert their shares, regardless of whether they vote for or against the proposed business
combination or do not vote at all, into their pro rata share of the aggregate amount on deposit in the trust account (net of taxes
payable), or (2) provide our shareholders with the opportunity to sell their shares to us by means of a tender offer (and thereby
avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount on deposit in the trust
account (net of taxes payable), in each case calculated as of two business days.

 prior to the consummation of the business combination and subject to the limitations described herein. If we determine to engage in a tender offer, such tender offer will be structured so that each shareholder may tender all of his, her or its shares rather than some pro rata portion of his, her or its shares. The decision as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Unlike other blank check companies which require shareholder votes and conduct proxy solicitations in conjunction with their initial business combinations and related conversions of public shares for cash upon consummation of such initial business combination even when a vote is not required by law, we will have the flexibility to avoid such shareholder vote and allow our shareholders to sell their shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act which regulate issuer tender offers. In that case, we will file tender offer documents with the SEC which will contain substantially the same financial and other information about the initial business combination as is required under the SEC's proxy rules. We will consummate our initial business combination only if we seek shareholder approval, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company.

 Our initial shareholders and our officers and directors have agreed (1) to vote any ordinary shares owned by them in favor of any proposed business combination, (2) not to redeem any ordinary shares in connection with a shareholder vote to approve a proposed initial business combination and (3) not sell any ordinary shares in any tender in connection with a proposed initial business combination.

 None of our officers, directors, initial shareholders or their affiliates has indicated any intention to purchase units or ordinary shares in the IPO or from persons in the open market or in private transactions. However, if we hold a general meeting to approve a proposed business combination and a significant number of shareholders vote, or indicate an intention to vote, against such proposed business combination or to convert their shares, our officers, directors, initial shareholders or their affiliates could make such purchases in the open market or in private transactions in order to influence the vote or increase the likelihood of satisfying the necessary closing conditions to such transaction. Notwithstanding the foregoing, our officers, directors, initial shareholders and their affiliates will not make purchases of ordinary shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act, which are rules designed to stop potential manipulation of a company's stock, shares or other equity securities.

 Redemption rights for public shareholders upon consummation of our initial business combination

 We will provide our public shareholders with the opportunity to redeem all or a portion their shares upon the consummation of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be $10.25 per share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the revised deferred underwriting commissions we will pay to the underwriters. Our initial shareholders have agreed to waive their right to receive liquidating distributions if we fail to consummate our initial business combination within the requisite time period. However, if our initial shareholders or any of our officers, directors or affiliates acquires public shares after the IPO, they will be entitled to receive liquidating distributions with respect to such public shares if we fail to consummate our initial business combination within the required time period.

 Manner of Conducting Redemptions

 At any general meeting called to approve an initial business combination, public shareholders may seek to redeem their shares, regardless of whether they vote for or against the proposed business combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination, less any taxes then due but not yet paid. Alternatively, we may provide our public shareholders with the opportunity to sell their ordinary shares to us through a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid.

 Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a "group" (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking redemption rights with respect to 20% or more of the shares sold in the IPO. Such a public shareholder would still be entitled to vote against a proposed business combination with respect to all shares owned by him or his affiliates. We believe this restriction will prevent shareholders from accumulating large blocks of shares before the vote held to approve a proposed business combination and attempt to use the redemption right as a means to force us or our management to purchase their shares at a significant premium to the then current market price. By limiting a shareholder's ability to redeem no more than 20% of the shares sold in the IPO, we believe we have limited the ability of a small group of shareholders to unreasonably attempt to block a transaction which is favored by our other public shareholders.

 Our initial shareholders, officers and directors will not have redemption rights with respect to any ordinary shares owned by them, directly or indirectly, whether acquired prior to the IPO or purchased by them in the IPO or in the aftermarket.

 We may require public shareholders, whether they are a record holder or hold their shares in "street name," to either (i) tender their certificates (if any) to our transfer agent or (ii) deliver their shares to the transfer agent electronically using Depository Trust Company's DWAC (Deposit/Withdrawal At Custodian) System, at the holder's option, in each case prior to a date set forth in the proxy materials sent in connection with the proposal to approve the business combination.

 There is a nominal cost associated with the above-referenced delivery process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically charge the tendering broker a nominal amount and it would be up to the broker whether or not to pass this cost on to the holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to deliver their shares prior to a specified date. The need to deliver shares is a requirement of exercising conversion rights regardless of the timing of when such delivery must be effectuated. However, in the event we require shareholders seeking to exercise redemption rights to deliver their shares prior to the consummation of the proposed business combination and the proposed business combination is not consummated this may result in an increased cost to shareholders.

 Any proxy solicitation materials we furnish to shareholders in connection with a vote for any proposed business combination will indicate whether we are requiring shareholders to satisfy such certification and delivery requirements. Accordingly, a shareholder would have from the time the shareholder received our proxy statement up until the vote on the proposal to approve the business combination to deliver his shares if he wishes to seek to exercise his redemption rights. This time period varies depending on the specific facts of each transaction. However, as the delivery process can be accomplished by the shareholder, whether or not he is a record holder or his shares are held in "street name," in a matter of hours by simply contacting the transfer agent or his broker and requesting delivery of his shares through the DWAC System, we believe this time period is sufficient for an average investor. However, we cannot assure you of this fact. Please see the risk factor titled "We will require public shareholders who wish to redeem their ordinary shares in connection with a proposed business combination to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights." in our IPO prospectus for further information on the risks of failing to comply with these requirements.

 Any request to redeem such shares once made, may be withdrawn at any time up to the vote on the proposed business combination or the expiration of the tender offer. Furthermore, if a holder of public shares delivered his certificate in connection with an election of their redemption and subsequently decides prior to the applicable date not to elect to exercise such rights, he may simply request that the transfer agent return the certificate (physically or electronically).

 If the initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account as of two business days prior to the consummation of the initial business combination. In such case, we will promptly return any shares delivered by public holders.

 Permitted purchases of our securities by our affiliates

 If we seek shareholder approval of our business combination and we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules, our initial shareholders, directors, officers or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the consummation of our initial business combination. Such a purchase would include a contractual acknowledgement that such shareholder, although still the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that our initial shareholders, directors, officers or their affiliates purchase shares in privately negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. Although very unlikely, our initial shareholders, officers, directors and their affiliates could purchase sufficient shares so that the initial business combination may be approved without the majority vote of public shares held by non-affiliates.

 The purpose of such purchases would be to (1) increase the likelihood of closing the business combination or (2) to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of the business combination, where it appears that such requirement would otherwise not be met. This may result in the consummation of an initial business combination that may not otherwise have been possible. To the extent that any public shares are purchased, such public shares will not be voted as required by Tender Offers and Schedules Compliance and Disclosure Interpretations Question 166.01 promulgated by the SEC.

 As a consequence of any such purchases, the public "float" of our ordinary shares may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain the listing or trading of our securities on a national securities exchange following consummation of a business combination.

 Redemption of public shares and liquidation if no initial business combination

 We will have until August 12, 2025 to consummate
an initial business combination. Pursuant to the terms of our Amended Articles of Association, as amended, and the Trust Agreement entered
into between us and Continental Stock Transfer & Trust Company on August 9, 2022, as amended on August 9, 2023 and August
12, 2024, in order to extend the time available for us to consummate our initial business combination, our sponsor or its affiliates or
designees, upon ten days advance notice prior to the applicable deadline, must deposit into the trust account $ 75,000 for each one month
extension. Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation
of our initial business combination. If we complete our initial business combination, we would repay such loaned amounts out of the proceeds
of the trust account released to us. If we do not complete a business combination, we will not repay such loans. Furthermore, the letter
agreement with our initial shareholders contains a provision pursuant to which our sponsor has agreed to waive its right to be repaid
for such loans out of the funds held in the trust account in the event that we do not complete a business combination. Our sponsor and
its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination.
You will not be able to vote on or redeem your shares in connection with any such extension.

 If we are unable to consummate our initial business combination within the allotted time period, we will, as promptly as reasonably possible but not more than five business days thereafter, distribute the aggregate amount then on deposit in the trust account (net of taxes payable, and less up to $50,000 of interest to pay liquidation expenses), pro rata to our public shareholders by way of redemption and cease all operations except for the purposes of winding up of our affairs. This redemption of public shareholders from the trust account shall be effected as required by function of our Amended Articles of Association, as amended, and prior to any voluntary winding up, although at all times subject to the Companies Act.

 Our initial shareholders have agreed to waive their redemption rights with respect to their founder shares if we fail to consummate our initial business combination within the applicable period from the closing of the IPO. However, if our initial shareholders, or any of our officers, directors or affiliates acquire public shares in or after the IPO, they will be entitled to redemption rights with respect to such public shares if we fail to consummate our initial business combination within the required time period. There will be no redemption rights or liquidating distributions with respect to our warrants or rights, which will expire worthless in the event we do not consummate our initial business combination within the allotted time period.

 If we were to expend all of the net proceeds of the IPO, other than the proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account, the per-share redemption amount received by shareholders upon our dissolution would be approximately $10.25. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the revised deferred underwriting commissions we will pay to the underwriters. The proceeds deposited in the trust account could, however, become subject to the claims of our creditors, which would have higher priority than the claims of our public shareholders. The actual per-share redemption amount received by shareholders may be less than $10.25, plus interest (net of any taxes payable, and less up to $50,000 of interest to pay liquidation expenses).

 Although we will seek to have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the trust account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party's engagement would be significantly more beneficial to us than any alternative. Making such a request of potential target businesses may make our acquisition proposal less attractive to them and, to the extent prospective target businesses refuse to execute such a waiver, it may limit the field of potential target businesses that we might pursue. Our independent registered public accounting firm will not execute agreements with us waiving such claims to the monies held in the trust account, nor will the underwriters of the IPO.

 If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party's engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. In order to protect the amounts held in the trust account, our sponsor has agreed that it will be liable to us, if and to the extent any claims by a vendor for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amounts in the trust account to below $10.25 per share, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third party claims. However, our sponsor may not be able to satisfy those obligations. Other than as described above, none of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses. We have not independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations. We therefore believe it is unlikely our sponsor would be able to satisfy its indemnity obligations if it was required to do so. However, we believe the likelihood of our sponsor having to indemnify the trust account is limited because we will endeavor to have all vendors and prospective target businesses as well as other entities execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account.

 In the event that the proceeds in the trust account are reduced below $10.25 per share and our sponsor asserts that it is unable to satisfy any applicable obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action to enforce such indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf to enforce such indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance. Accordingly, due to claims of creditors, the actual value of the per-share redemption price may be less than $10.25 per share.

 If we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy or insolvency estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy or insolvency claims deplete the trust account, we cannot assure you we will be able to return $10.25 per share to our public shareholders. Additionally, if we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a "preferential transfer", a "fraudulent conveyance", a "fraud in anticipation of winding up", a "transaction in fraud of creditors" or a "misconduct in the course of winding up". As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.

 Our public shareholders will be entitled to receive funds from the trust account only (i) in the event of a redemption of the public shares prior to any winding up in the event we do not consummate our initial business combination within the allotted time period, (ii) if they redeem their shares in connection with an initial business combination that we consummate or (iii) if they redeem their shares in connection with a shareholder vote to amend our Amended Articles of Association, as amended, (A) to modify the substance or timing of our obligation to allow redemption rights or to redeem 100% of our public shares if we do not complete our initial business combination within the allotted time period or (B) with respect to any other provision relating to shareholders' rights or pre-business combination activity. In no other circumstances shall a shareholder have any right or interest of any kind to or in the trust account. In the event we seek shareholder approval in connection with our initial business combination, a shareholder's voting in connection with the business combination alone will not result in a shareholder's redeeming its shares to us for an applicable pro rata share of the trust account. Such shareholder must have also exercised its redemption rights described above.

 Competition

 If the Business Combination with Tianji does not
close, in identifying, evaluating and selecting a target business for our initial business combination, we may encounter intense competition
from other entities having a business objective similar to ours, including other blank check companies, private equity groups, venture
capital funds leveraged buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established
and have significant experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these
competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will
be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target
business. Furthermore, the requirement that we acquire a target business or businesses having a fair market value equal to at least 80%
of the value of the trust account (less any revised deferred underwriting commissions and taxes payable on interest earned) at the time
of the agreement to enter into the business combination, our obligation to pay cash in connection with our public shareholders who exercise
their redemption rights and the future dilution they potentially represent, may not be viewed favorably by certain target businesses.
Any of these factors may place us at a competitive disadvantage in successfully negotiating our initial business combination.

 Employees

 We currently have two executive officers. These individuals are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time they will devote in any time period will vary based on whether a target business has been selected for our initial business combination and the stage of the business combination process we are in. We do not intend to have any full time employees prior to the consummation of our initial business combination.

 Available Information

 We are required to file Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q with the SEC on a regular basis, and are required to disclose certain material events in a Current Report on Form 8-K. The SEC maintains an Internet website that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. The SEC's Internet website is located at www.sec.gov. In addition, the Company will provide copies of these documents without charge upon request from us in writing at 5186 Carroll Canyon Rd, San Diego, CA 92121 or by telephone at (858) 688-4965.

 ITEM 1A.

 RISK FACTORS

 As a smaller reporting company, we are not required to make disclosures under this Item. As of the date of this Annual Report on Form 10-K, there have been no material changes to the risk factors disclosed in our IPO prospectus dated August 9, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition.

 ITEM 1B.

 UNRESOLVED STAFF COMMENTS

 Not applicable.

 ITEM 1C.

 CYBERSECURITY

 We are a SPAC with no business operations. Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if there is any. We have not encountered any cybersecurity incidents since our IPO.

 ITEM 2.

 PROPERTIES

 We currently maintain our executive offices at
5186 Carroll Canyon Rd, San Diego, CA 92121. Such space is provided to us free of charge by our sponsor. We consider our
current office space adequate for our current operations.

 ITEM 3.

 LEGAL PROCEEDINGS

 We may be subject to legal proceedings, investigations and claims incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

 ITEM 4.

 MINE SAFETY DISCLOSURES

 Not Applicable.

 ITEM 5.

 MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 Our units began to trade on The Nasdaq Capital Market, or Nasdaq, under the symbol "EMCGU" on August 10, 2022. The ordinary shares, rights and warrants comprising the units began separate trading on Nasdaq on September 30, 2022, under the symbols "EMCG," "EMCGR," and "EMCGW," respectively.

 Holders of Record

 As of December 31,
2024, there were 4,123,027 of our ordinary shares issued and outstanding held by five stockholders of record, excluding 396,997
ordinary shares underlying the units. The number of record holders was determined from the records of our transfer agent and does not
include beneficial owners of ordinary shares whose shares are held in the names of various security brokers, dealers, and registered
clearing agencies.

 Dividends

 We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any dividends subsequent to our initial business combination will be within the discretion of our then board of directors at such time and we will only pay such dividend out of our profits or share premium (subject to solvency requirements) as permitted under Cayman Islands law. It is the present intention of our board of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring any dividends in the foreseeable future.

 Securities Authorized for Issuance Under Equity Compensation Plans

 None.

 Recent Sales of Unregistered Securities

 None.

 Use of Proceeds

 On August 12, 2022, we consummated our IPO of 7,392,855 Public Units (including the issuance of 892,855 Units as a result of the underwriter's partial exercise of its over-allotment option), each Public Unit consisting of one ordinary share, par value $0.0001 per share, one right to receive one-eighth (1/8) of one ordinary share upon the consummation of an initial business combination, and one warrant to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described in the IPO prospectus. The Public Units were sold at a price of $10.00 per Public Unit, generating gross proceeds to us of $73,928,550. As a result of the partial exercise of the Representative's Over-Allotment Option, an aggregate of 20,536 founder shares were forfeited to the Company of which was reflected retroactively.

 Simultaneously with the closing of the IPO on August 12, 2022, we consummated the Private Placement with Wuren Fubao Inc., our sponsor, purchasing 373,750 units (the "Private Units"), generating total proceeds of $3,737,500. The Private Units are identical to the Units sold in the IPO except that the holder has agreed not to transfer, assign, or sell any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until the completion of the Company's initial business combination. In addition, the warrants included in the Private Units are not redeemable if held by them or a permitted transferee. The sponsor was granted certain demand and piggy-back registration rights in connection with the purchase of the Private Units.

 Following the closing of the Initial Public Offering on August 12, 2022, an amount of $75,776,764 ($10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and a portion of the proceeds from the sale of the Private Units was placed in a trust account (the "Trust Account") and may be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company's shareholders, as described below.

 The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a business combination solely if a vote is held to approve a business combination, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company.

 We paid a total of $739,286 in underwriting discounts and commissions (not including the revised deferred underwriting commission payable at the consummation of business combination) and $571,245 for other costs and expenses related to the IPO.

 For a description of the use of the proceeds generated in our initial public offering, see below Part II, Item 7 – Management's Discussion and Analysis of Financial Condition and Results of Operations of this Form 10-K.

 Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 None.

 ITEM 6.

 [RESERVED]

 As a smaller reporting company, we are not required to make disclosures under this Item.

 ITEM 7.

 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are included in "Item 8. Financial Statements and Supplementary Data" of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under "Special Note Regarding Forward-Looking Statements," and elsewhere in this Annual Report on Form 10-K.

 Special Note Regarding Forward-Looking Statements

 All statements other than statements of historical fact included in this Annual Report including, without limitation, statements under this "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding our financial position, business strategy and the plans and objectives of management for future operations, are forward looking statements. When used in this Annual Report, words such "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or other similar expressions, as they relate to us or our management, identify forward looking statements. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings. Such forward looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. No assurance can be given that results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. The cautionary statements made in this Annual Report should be read as being applicable to all forward-looking statements whenever they appear in this Annual Report. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

 Overview

 We are a blank check company incorporated in the Cayman Islands for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our Business Combination using cash from the proceeds of the initial public offering (the "IPO") and the private placement of the private placement units, the proceeds of the sale of our securities in connection with our Business Combination, our shares, debt or a combination of cash, stock and debt.

 We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 Recent Developments

 Initial Public Offering

 On August 12, 2022, the Company consummated
its initial public offering of 7,392,855 units (the "Units", and, with respect to the ordinary shares included in the Units
being offered, the "Public Shares"), including the issuance of 892,855 Units as a result of the partial exercise by EF Hutton,
division of Benchmark Investments, LLC (the "Representative") of its over-allotment option (the "Over-Allotment Option"),
at $10.00 per Unit, generating gross proceeds of $73,928,550 (the "Initial Public Offering").

 Simultaneously with the closing of the IPO, the
Company consummated the private placement ("Private Placement") with the Sponsor of 373,750 units (the "Private Units"),
generating total proceeds of $3,737,500.

 Following the closing of the Initial Public Offering
on August 12, 2022, an amount of $75,776,764 ($10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public
Offering and a portion of the proceeds from the sale of the Private Units was placed in a trust account (the "Trust Account").

 Transaction costs of the Initial Public Offering
with the exercise of the over-allotment amounted to $3,898,030 consisting of $739,286 of up-front underwriting fees and a deferred discount
of $2,587,499 and $571,245 of other costs. As of closing, $760,003 of the proceeds from the IPO was held outside of the Trust Account
and is available for working capital purposes. For the year ended December 31, 2023, the Company charged $210,873 in offering cost
to accumulated deficit.

 Extension and Redemption

 On August 9, 2023, the Company held an extraordinary
general meeting of shareholders (the " First Extraordinary General
Meeting "), at which the Company ' s
shareholders approved the following proposals: (a) as a special resolution, giving the Company the right to extend the date by which the
Company must consummate a business combination (the " Combination
Period ") twelve (12) times for an additional one (1) month each
time, from August 12, 2023 (i.e. the end of 12 months from the consummation of its Initial Public Offering, the " Termination
Date ") to August 12, 2024, by depositing into the Trust Account
the lesser of $100,000 or $0.045 per outstanding public share for each one-month extension (the " Initial
Extension Payment ") (the " First
Extension Amendment Proposal ") by deleting the amended and restated
memorandum and articles of association (the " Articles of Association ")
in its entirety and substitute it with the second amended and restated memorandum and articles of association of the Company (the " Amended
Articles of Association "); (b) as an ordinary resolution, an amendment
to the investment management trust agreement dated as of August 9, 2022 (the " Trust
Agreement ") between the Company and Continental Stock Transfer &
Trust Company (the " Trustee "),
to extend the Combination Period from the Termination Date to the August 12, 2024, by depositing into the Trust Agreement the Initial
Extension Payment (the " First Trust Agreement Amendment Proposal ");
and (c) as a special resolution, an amendment to the Articles of Association to remove the net tangible asset requirement from the Articles
of Association in order to expand the methods that the Company may employ so as not to become subject to the " penny
stock " rules of the Securities and Exchange Commission by deleting
the Articles of Association in its entirety and substitute it with the second amended and restated memorandum and articles of association
of the Company (the " NTA Requirement Amendment Proposal ").
In connection with the shareholders' vote at the First Extraordinary General Meeting, 1,550,710 ordinary shares were tendered for
redemption. On August 14, 2023, the Company accepted a reversal request for 109,819 shares. As a result, a total of 1,440,891 ordinary
shares were redeemed at a redemption price of approximately $10.68 per share, for an aggregate redemption amount of $15,385,924, leaving
5,951,964 ordinary shares subject to possible redemption still outstanding after the August 2023 redemption.

 On October 20, 2023, the Company held an
annual general meeting of shareholders (the "2023 Annual General Meeting"), at which the Company's shareholders approved
to amend the Amended Articles of Association by removing the restriction of the Company to undertake a Business Combination with any entity
or business based in, or with its principal or a majority of its business operations (either directly or through any subsidiaries) in,
the People's Republic of China (including Hong Kong and Macau). In connection with the Annual General Meeting, holders of 824,682
ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.81
per share, for an aggregate redemption amount of $8,911,074, leaving 5,127,282 ordinary shares subject to possible redemption still outstanding
after the October 2023 redemption.

 From August 2023 to December 2023, the
Company deposited five tranches of $100,000, for an aggregated of $500,000 into the Trust Account, extending the Termination Date to January 12,
2024. From January 2024 to August 2024, the Company deposited additional seven tranches of $100,000, for an aggregated of $700,000
into the Trust Account, extending the Termination Date to August 12, 2024.

 On August 12, 2024, the Company held an extraordinary
general meeting of shareholders (the "Second Extraordinary General Meeting"), at which, the Company and its Trustee signed
an amendment to the investment management Trust Agreement, to give the Company the right to extend the Combination Period twelve (12)
times for an additional one (1) month each time, from August 12, 2024 to August 12, 2025 (the "Extended Date"), by depositing
into the Trust Account $75,000 for each one-month extension (the "Amended Extension Payment"), as approved by the Company's
shareholders in accordance with the Company's Amended Articles of Association. At the Second Extraordinary General Meeting, the
shareholders of the Company approved a special resolution to the Amended Articles of Association to extend the Combination Period from
the Termination Date to the Extended Date and to delete words "(less up to US$50,000 of interest to pay dissolution expenses)".

 In connection with the shareholders' vote
at the Second Extraordinary General Meeting held by the Company on August 12, 2024, 2,903,151 ordinary shares were tendered for redemption,
leaving 2,224,131 ordinary shares subject redemption still outstanding after the August 2024 redemption.

 On September 10, 2024, the Company deposited $75,000
into the Trust Account, extending the Termination Date to September 12, 2024. The Company has the right to extend the Combination Period
eleven (11) more times for an additional one (1) month each time, from September 12, 2024 to August 12, 2025. Up to the date
the financial statements were issued, there was no additional deposits made other than the payment that was made on September 10, 2024. The Company is obligated to deposit another six tranches of $75,000, for an aggregate of $450,000,
to the Trust Account, to extend the date that the Company has to consummate a business combination to March 12, 2025.

 Nasdaq Notices

 On October 12, 2023,
the Company received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating
that the Company is not in compliance with Listing Rule 5450(a)(2) of The Nasdaq Global Market in connection with its listing of
the Company's ordinary shares, par value $0.001 per share, which requires the Company to maintain a minimum of 400 total holders
of its ordinary shares for continued listing on The Nasdaq Global Market. The notice is only a notification of deficiency, not of imminent
delisting, and has no current effect on the listing or trading of the Company's securities on The Nasdaq Global Market. The notice
states that the Company has until November 27, 2023 to submit a plan to regain compliance with Listing Rule 5450(a)(2). If Nasdaq
accepts the Company's plan, Nasdaq may grant the Company an extension of up to 180 calendar days from October 12, 2023, the
date of the Notice, to evidence compliance with Listing Rule 5450(a)(2). If Nasdaq does not accept the Company's plan, the
Company will have the opportunity to appeal Nasdaq's determination. Alternatively, the Company may consider applying for a transfer
to The Nasdaq Capital Market. In order to transfer, the Company must submit an on-line transfer application, pay the $5,000 application
fee, and meet The Nasdaq Capital Market's continued listing requirements. The Company submitted a compliance plan to Nasdaq on November 27,
2023.

 On December 22,
2023, the Company received a notification from Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had
failed to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the "Form 10-Q"). Under
the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq
may grant an exception of up to 180 calendar days from the Form 10-Q's due date, or until May 20, 2024, to regain compliance.
The Company later filed the Form 10-Q on March 1, 2024.

 On April 23, 2024, the
Company received a delisting determination letter from the Listing Qualifications of Nasdaq advising the Company that the Company has
not paid its assessed fees required by Listing Rule 5250(f). The Company subsequently paid the outstanding fee.

 On May 30, 2024, the
Company received a delinquency notification letter from Nasdaq due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1)
as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31,
2024.

 On June 24, 2024, the Company received a notice
from Nasdaq indicating that, unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the "Panel") by
4:00 p.m. Eastern Time on July 1, 2024, the Company's securities (units, ordinary shares, warrants, and rights) would be subject
to suspension and delisting from The Nasdaq Global Market at the opening of business on July 3, 2024, due to the Company's non-compliance
with the Minimum Holders Rule and the Reporting Rule. The Company timely requested a hearing before the Panel to appeal the Staff Determination
and submitted a request for extension of stay. The suspension referenced in the Staff Determination has been stayed for a period of 15
calendar days until July 16, 2024 and the hearing has been scheduled on August 1, 2024.

 On July 12, 2024, the Company submitted a written
submission to Nasdaq. On July 25, 2024, the Company received a notice from Nasdaq indicating the grant of the Company's request
to extend the stay of suspension pending a hearing on August 1, 2024, and issuance of a final Panel decision. On August 1, 2024, the Company
attended the Nasdaq hearing before the Panel.

 On September 5, 2024, the Company received a delinquency
notification letter from Nasdaq due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company's
failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024. On September 16, 2024, the Company
filed its Form 10-Q for the fiscal quarter ended June 30, 2024.

 On October 30, 2024, the Company received a letter
from Nasdaq which confirmed that the Company regained compliance on September 16, 2024 with the filing requirement in Listing Rule 5250(c),
as required by the Nasdaq hearing panel's decision dated August 14, 2024. The Company is subject to a mandatory panel monitor for
a period of one year from September 16, 2024. Under the terms of the panel monitor, in the event the Company is again out of compliance
with the periodic filing rule during the monitoring period, the Company will have an opportunity to request a new hearing before the panel
in order to maintain its listing, rather than being granted additional time to regain compliance or being afforded an applicable cure
or compliance period.

 Satisfaction and Discharge Agreement

 On March 4, 2024,
the Company and EF Hutton entered into a Satisfaction and Discharge of Indebtedness Pursuant to Underwriting Agreement dated August 9,
2022 (the "Satisfaction and Discharge Agreement"), pursuant to which, EF Hutton agreed to revise the deferred underwriting
fee of three point five percent (3.50%) of the gross proceeds of the initial public offering, or $2,587,499, to (1) $750,000 in cash on
the date of the closing of the initial business combination (the "Closing") and (2) 200,000 of registered and unrestricted
shares of the Company, shall be issued and delivered to EF Hutton at the Closing.

 Financing from Debt

 From July 2024 to December 2024, the Company received
$775,000 from a subsidiary of Tianji (as defined below). These amounts are unsecured, non-interest bearing and due on demand. From January
2025 to March 2025, the Company borrowed $200,000 from Tianji and its subsidiaries, these amounts are unsecured, non-interest bearing and
due on demand.

 On August 5, 2024, the Company borrowed $300,000
from another unrelated third party, by issuing a promissory note. The unpaid principal balance of this note bears an annual interest rate
of nine point one two seven percent (9.127%) per annum. The note will be due two months after executed. On August 6, 2024, the Company
received the $300,000 in full under such note. On September 10, 2024, and September 27, 2024, the Company repaid $100,000 and $150,000,
respectively, to the payee, leaving $50,000 in principal unpaid as of December 31, 2024. On October 5, 2024, the remaining principal
of $50,000 was due and will be payable on demand. Up to the date the financial statements were issued, the principal of $50,000 remained
unpaid and past due.

 For the year ended December 31, 2024, the Company
recorded $4,664 in interest expenses under the promissory note - third party. As of December 31, 2024, the total outstanding under the
promissory note- third party was $54,664.

 Business Combination Agreement

 On January 26, 2025, the Company entered into
a merger agreement (as it may be amended, supplemented, or otherwise modified from time to time, the "Merger Agreement"),
by and between the Company, EMC Merger Sub 1, a Cayman Islands exempted company and wholly owned subsidiary of the Company ("Purchaser"),
EMC Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of Purchaser ("Merger Sub"), and Tianji Tire
Global (Cayman) Limited, a Cayman Islands exempted company ("Tianji"), pursuant to which (a) the Company will be merged with
and into Purchaser (the "Reincorporation Merger"), with Purchaser surviving the Reincorporation Merger, and (b) Merger Sub
will be merged with and into Tianji (the "Acquisition Merger"), with Tianji surviving the Acquisition Merger as a direct wholly
owned subsidiary of Purchaser (collectively, the "Business Combination"). Following the Business Combination, Purchaser will
be a publicly traded company.

 Consideration

 At the effective time of the Acquisition Merger,
each Tianji Class A ordinary share will be converted into the right to receive one Reincorporation Merger Surviving Corporation Class
A ordinary share and each Tianji Class B ordinary share will be converted into the right to receive one Reincorporation Merger Surviving
Corporation Class B ordinary share, as outlined in the Merger Agreement.

 Purchaser will issue an aggregate of 45,000,000
of its ordinary shares ("Purchaser Ordinary Shares") with a deemed price per share of US$10.00, for a total value equal to
the merger consideration, $450,000,000 (the "Merger Consideration Shares"), to the shareholders of Tianji (the "Tianji
Shareholders") at the Business Combination closing (the "Closing"). Upon Closing, the Tianji Shareholders will no longer
hold any rights in the Tianji ordinary shares they held prior to the Closing, and they will hold the right to receive their portion of
the Merger Consideration Shares pursuant to the Merger Agreement.

 Issuance of Share Consideration

 In connection with the Acquisition Merger, fractional
shares of the Purchaser Ordinary Shares that would otherwise be issued to the Tianji Shareholders will be rounded down to the nearest
whole share.

 Results of Operations

 We have neither engaged in any operations nor
generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for
our IPO and after our IPO, searching for a business combination target. Following our IPO, we will not generate any operating revenues
until after completion of our Business Combination. We will generate non-operating income in the form of interest income on cash and cash
equivalents after our IPO. There has been no significant change in our financial or trading position and no material adverse change has
occurred since the date of our financial statements. We expect that we will incur increased expenses as a result of being a public company
(for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing
a business combination.

 For the year ended December 31, 2024, we had a
net income of $1,442,593 which consists of investment income earned on investments held in trust account of $2,377,420 partially offset
by operating costs of $551,662 and loss on modification of deferred underwriter commission of $378,501 and interest expense of $4,664.

 For the year ended December 31, 2023, we had a
net income of $2,424,391 which consists of investment income earned on investments held in trust account of $3,486,597 partially
offset by operating costs of $1,062,206.

 Liquidity and Capital Resources

 As of December 31, 2024, we had cash of $66,985
on our balance sheet and a working capital deficit of $2,857,923.

 We intend to use the funds held outside of the
Trust Account, proceeds from Convertible Promissory Notes (as described below) and loans received from the unrelated third parties (as
described below) for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target
businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents
and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating
the Business Combination. The interest income earned on the investments held in the Trust Account are unavailable to fund
operating expenses.

 In order to finance transaction costs in connection
with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor, or the Company's officers and directors
may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). Such Working Capital Loans
would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest,
or, at the lender's discretion, up to $500,000 of notes may be converted upon consummation of a Business Combination into additional
Private Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of
proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to
repay the Working Capital Loans. As of December 31, 2024 and 2023, the Company borrowed $241,112 and $90,112, respectively, which was
included in convertible promissory note - related party.

 On September 8, 2023, the Company borrowed
$10,000 from the Sponsor. The loan bears no interest and is repayable in full upon the consummation of the Company's Business Combination.
It is convertible at the Sponsor's election upon the consummation of the Company's Business Combination. Upon such election,
this loan will convert, at a price of $10.00 per unit, into units identical to the private placement units issued in connection with the
Company's initial public offering.

 From October 2023 to December 2024, the
Company borrowed $841,112 in total from our Chief Financial Officer, in form of convertible promissory notes, for working capital
and extension deposits purposes (as described in Note 5 of the Notes to the Financial Statements). These loans bear no interest and
are repayable in full upon the consummation of the Company's Business Combination. They are convertible at the CFO's
election upon the consummation of the Company's Business Combination. Upon such election, these loans will convert, at a price
of $10.00 per unit, into units identical to the private placement units issued in connection with the Company's initial public
offering. Up to the date the financial statements were available to be issued, the total amounts borrowed from the CFO under
convertible promissory notes were $841,112.

 From October 2023 to December 2024, the
Company's CFO also paid $144,060, on behalf of us, to the third-party vendors for working capital purposes. These amounts are
unsecured, non-interest bearing and due on demand. Up to the date the financial statements were available to be issued, the total
amounts paid by the CFO were $144,060.

 From July 2024 to December 2024, the Company borrowed
$775,000 from Tianji and its subsidiaries. These amounts are unsecured, non-interest bearing and due on demand. The Company recorded
them as due to third party on the balance sheet. As of December 31, 2024, the total due to third party was $775,000. From January 2025
to March 2025, the Company borrowed $200,000 from Tianji and its subsidiaries, these amounts are unsecured, non-interest bearing and
due on demand. Up to the date the financial statements were issued, the Company received $975,000 from Tianji and its subsidiaries
in total.

 On August 5, 2024, the Company borrowed $300,000
from another unrelated third party, by issuing a promissory note. The unpaid principal balance of this note bears an annual interest rate
of nine point one two seven percent (9.127%) per annum. The note will be due two months after executed. On August 6, 2024, the Company
received the $300,000 in full under such note. On September 10, 2024, and September 27, 2024, the Company repaid $100,000 and $150,000,
respectively, to the payee, leaving $50,000 in principal unpaid as of December 31, 2024. For the year ended December 31, 2024, the Company
recorded $4,664 in interest expenses under the promissory note - third party. As of December 31, 2024, the total outstanding under the
promissory note - third party was $54,664. On October 5, 2024, the remaining principal of $50,000 was due and will be payable
on demand. Up to the date the financial statements were issued, the principal of $50,000 remained unpaid and past due.

 Going Concern Consideration

 The Company expects to incur significant costs
in pursuit of its financing and acquisition plans. In connection with the Company's assessment of going concern considerations in
accordance with Accounting Standards Update ("ASU") 2014-15,"Disclosures of Uncertainties about an Entity's Ability
to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an Initial Business
Combination by August 12, 2025 (subject to the Amended Extension Payment is made as required for each monthly extension), the requirement
that the Company cease all operations, redeem the Public Shares and thereafter liquidate and dissolve raises substantial doubt about the
Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the
outcome of this uncertainty. The accompanying financial statement has been prepared in conformity with generally accepted accounting principles
in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern.

 Off-Balance Sheet Financing Arrangements

 We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of December 31, 2024. We do not participate in transactions that create
relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial
assets.

 Contractual Obligations

 We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities. The underwriter is entitled to a deferred fee of three point five percent
(3.50%) of the gross proceeds of the Offering upon closing of the Business Combination, or $2,587,499. On March 4, 2024, we and the
underwriter, entered into a satisfaction and discharge of indebtedness pursuant to underwriting agreement dated August 9, 2022 (the
"Satisfaction and Discharge Agreement"), pursuant to which, the underwriter agreed to revise the deferred underwriting fee
of $2,587,499, to (1) $750,000 in cash on the date of the closing of the initial business combination (the "Closing") and
(2) 200,000 of registered and unrestricted shares of us, shall be issued and delivered to the underwriter at the Closing. The deferred
fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of
the underwriting agreement.

 Critical Accounting Estimates

 The preparation of financial statements and related
disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
As of December 31, 2024, there were no critical accounting estimates.

 Recent Accounting Standards

 In November 2023, the FASB issued ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual
and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker ("CODM"),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide
all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal
years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption
permitted. The Company adopted ASU 2023 - 07 in fiscal year 2024 and there was no significant impact.

 Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on the Company's financial statements.

 Off-Balance Sheet Arrangements; Commitments
and Contractual Obligations; Fiscal Results

 As of the date of this report, we did not have
any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual
obligations.

 ITEM 7A.

 Quantitative and Qualitative Disclosures about Market Risk

 As a smaller reporting company, we are not required to make disclosures under this Item.

 ITEM 8.

 Financial Statements and Supplementary Data

 This information appears following Item 15 of this Report and is included herein by reference.

 ITEM 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 None.

 ITEM 9A.

 Controls and Procedures.

 Evaluation of Disclosure Controls and Procedures

 Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC's rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our "Certifying Officers"), the effectiveness of our disclosure controls and procedures as of December 31, 2024, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of December 31, 2024, our disclosure controls and procedures were not effective.

 We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 Management's Report on Internal Controls Over Financial Reporting

 As required by SEC rules and regulations implementing
Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial
reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal control
over financial reporting includes those policies and procedures that:

 (1)
 pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and dispositions of the assets of our company,

 (2)
 provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our
management and directors, and

 (3)
 provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use
or disposition of our assets that could have a material effect on the financial statements.

 Because of its inherent limitations, internal
control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal
control over financial reporting on December 31, 2024. In making these assessments, management used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments
and those criteria, management determined that we did not maintain effective internal control over financial reporting as of December
31, 2024, due to the material weakness in our internal controls due to inadequate segregation of duties within account processes due to
limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.

 Management intends to implement remediation steps
to improve our internal controls due to inadequate segregation of duties within account processes due to limited personnel and insufficient
written policies and procedures for accounting, IT, and financial reporting and record keeping. We plan to further improve this process
by enhancing the size and composition of our board upon the closing of the business and to identify third-party professionals with whom
to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training
to supplement existing accounting professionals and implemented additional layers of reviews in the financial close process.

 This Annual Report on Form 10-K does not include
an attestation report of our independent registered public accounting firm due to our status as an emerging growth company under the JOBS
Act.

 Changes in Internal Control over Financial Reporting

 There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 ITEM 9B.

 Other Information.

 None.

 ITEM 9C.

 Disclosure Regarding Foreign Jurisdictions That Prevent Inspections

 None.

 ITEM 10.

 Directors, Executive Officers and Corporate Governance.

 The following table sets forth information about
our directors and executive officers as of March 11, 2025.

 Name

 Age

 Position

 Jingyu Wang

 Chief Executive Officer and Director

 Zheng Yuan

 Chief Financial Officer and Director

 Jiangping (Gary) Xiao

 Independent Director

 Mo Zhou

 Independent Director

 Hang Zhou

 Independent Director

 Below is a summary of the business experience of each our executive officers and directors:

 Jingyu Wang has been our Chief Executive Officer and director since December 2022. Mr. Wang served as an advisor to the Company in connection with its initial public offering and public disclosures from September 2021 until his appointment as Chief Executive Officer. From June 2015 to September 2021, Mr. Wang served as the secretary of the board for 36Kr Holdings Inc., a company listed on Nasdaq (Nasdaq: KRKR), for which he coordinated the Company's public disclosures. Mr. Wang received his bachelor's degree in laws from China University of Political Science and Law in 2012. We believe Mr. Wang is qualified to serve on our board of directors because of his extensive capital markets experience, as well as his contacts and relationships.

 Zheng Yuan has been our Chief Financial Officer and a director since March 2021. From June 2017 until August 2021, Ms. Yuan was the Acting as CFO and Administrative Director of Ningbo Super fan Culture Media Co., Ltd., a joint stock limited company. From October 2010 until March 2016, she was the Vice President of International Banking for Bank of Beijing Co., Ltd. She received master's and bachelor's degrees from Tianjin University of Finance and Economics. We believe that Ms. Zheng Yuan's extensive and long-term multinational financial management experience will help us to better identify the financial risks of potential investment targets and to find outstanding companies to acquire.

 Jiangping (Gary) Xiao has been our independent director since May 2022. He has been the CFO at Big Red Rooster Flow, LLC since June 2021. From July 2019 until April 2021, he served as Vice President of Finance & Accounting for Hilco IP Merchant Bank. From March 2017 until March 2019, he served as Chief Financial Officer for Professional Diversity Network, Inc. (Nasdaq: IPDN). From June 2013 until April 2016, he served as the Chief Financial Officer and Controller of Petstages Inc. Mr. Xiao has also been an independent director for several public companies. From July 2019 to November 2021, Mr. Xiao served as an independent board director of Takung Art Co. Ltd. (NYSE: TKAT). From December 2020 to July 2021, Mr. Xiao served as an independent director and the chairman of the nominating and corporate governance committee of Wunong Net Technology Co. Ltd. (Nasdaq: WNW). He received a master's degree in business administration from the Ross School of Business at the University of Michigan and a bachelor's degree in accounting from Tsinghua University. We believe that Mr. Xiao is qualified to serve as an independent director due to his broad range of experience, including accounting, auditing, financial planning and analysis, merger and acquisitions, SEC reporting, SOX compliance, HR and IT management.

 Mo Zhou has served as our independent director since December 2022. Mr. Zhou has been serving as the Chief Operating Officer of Destone Acquisition Corp. and the Chief Risk Officer of Destone Holdings LLC since June 2021. Mr. Zhou was a lawyer at Davis Polk & Wardwell LLP from October 2014 to May 2021. Mr. Zhou received his bachelor's degree in commerce from Queen's University in 2010 and his Juris Doctor degree from Harvard Law School in 2014. We believe that Mr. Zhou is qualified to serve as an independent director because of his rich legal and SPAC experiences.

 Hang Zhou has been our independent director since May 2022. Since June 2016, he has been the vice president for product/channel management of ARRIS Group which was acquired by CommScope Inc. in 2019. From 2013 to June 2016, Hang Zhou was the vice president and general manager in Greater China region of ARRIS Group. From 2009 to 2013, Mr. Zhou was the general manager and senior director of product management at Hangzhou Motorola Technology Ltd., which was a subsidiary of Motorola Inc.'s home division. From 2001 to 2009, Hang Zhou worked at Motorola Inc.'s home division. Hang Zhou received his MBA degree from Temple University in 1998, and his bachelor of arts in international relations from Foreign Affairs College in China in 1994. We believe that Mr. Zhou is qualified to serve as an independent director due to his rich experience in developing new businesses and products in domestic and international markets.

 Director Independence

 Nasdaq requires that a majority of our board must be composed of "independent directors," which is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company's board of directors would interfere with the director's exercise of independent judgment in carrying out the responsibilities of a director.

 Jiangping (Gary) Xiao, Mo Zhou and Hang Zhou are our independent directors. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Any affiliated transactions will be on terms no less favorable to us than could be obtained from independent parties. Any affiliated transactions must be approved by a majority of our independent and disinterested directors.

 Executive Officer and Director Compensation

 No compensation will be paid to our initial shareholders, officers and directors, or any of their respective affiliates, prior to or in connection with the consummation of our initial business combination. Additionally, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our independent directors will review on a quarterly basis all payments that were made to our initial shareholders, officers, directors or our or their affiliates.

 After the completion of our initial business combination, members of our management team who remain with us, may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time, as it will be up to the directors of the post-combination business to determine executive and director compensation. Any compensation to be paid to our officers will be determined, or recommenced, to the board of directors for determination, either by a committee constituted solely by independent directors or by a majority of the independent directors on our board of directors.

 We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management's motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.

 Audit Committee

 We have established an audit committee of the board of directors. Jiangping (Gary) Xiao, Mo Zhou and Hang Zhou serve as members of our audit committee. Jiangping (Gary) Xiao chairs the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have three members of the audit committee all of whom must be independent. Jiangping (Gary) Xiao, Mo Zhou and Hang Zhou are independent.

 Each member of the audit committee is financially literate and our board of directors has determined that Jiangping (Gary) Xiao qualifies as an "audit committee financial expert" as defined in applicable SEC rules.

 Responsibilities of the audit committee include:

 the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us;

 pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;

 reviewing and discussing with the independent registered public accounting firm all relationships the auditors have with us in order to evaluate their continued independence;

 setting clear hiring policies for employees or former employees of the independent registered public accounting firm;

 setting clear policies for audit partner rotation in compliance with applicable laws and regulations;

 obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing the independent auditor's internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;

 reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and

 reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

 Compensation Committee

 We have established a compensation committee of the board of directors. The members of our Compensation Committee are Jiangping (Gary) Xiao, Mo Zhou and Hang Zhou. Hang Zhou chairs the compensation committee. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

 reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer's compensation, evaluating our Chief Executive Officer's performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation in executive session at which the Chief Executive Officer is not present;

 reviewing and approving the compensation of all of our other officers;

 reviewing our executive compensation policies and plans;

 implementing and administering our incentive compensation equity-based remuneration plans;

 assisting management in complying with our proxy statement and annual report disclosure requirements;

 approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;

 producing a report on executive compensation to be included in our annual proxy statement; and

 reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.

 The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.

 Director Nominations

 We have established a nominating committee of the board of directors, which consist of Jiangping (Gary) Xiao, Mo Zhou and Hang Zhou, each of whom is an independent director under Nasdaq's listing standards. Hang Zhou chairs the nominating committee. The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others.

 Guidelines for Selecting Director Nominees

 The guidelines for selecting nominees, which are specified in the Nominating Committee Charter, generally provide that persons to be nominated:

 should have demonstrated notable or significant achievements in business, education or public service;

 should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and

 should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders.

 The Nominating Committee will consider a number of qualifications relating to management and leadership experience, background, integrity and professionalism in evaluating a person's candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons.

 Code of Conduct and Ethics

 We have adopted a code of conduct and ethics applicable to our directors, officers and employees in accordance with applicable federal securities laws. We have filed a copy of our form of Code of Ethics and our audit committee charter as exhibits to the registration statement related to our IPO. You are able to review these documents by accessing our public filings at the SEC's web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K.

 Conflicts of Interest

 Potential investors should be aware of the following potential conflicts of interest:

 None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.

 In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.

 Our initial shareholders purchased founder shares prior to the IPO and our sponsor purchased the private units in transactions that closed simultaneously with the closing of the IPO. Our initial shareholders have agreed to waive their right to liquidating distributions with respect to its founder shares if we fail to consummate our initial business combination within the required time period. However, if our initial shareholders also acquire public shares after the IPO, they will be entitled to receive liquidating distributions with respect to such public shares if we fail to consummate our initial business combination within the required time period. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private units will be used to fund the redemption of our public shares, and the private units will expire worthless.

 Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.

 Under Cayman Islands law, directors and officers owe the following fiduciary duties:

 (i)

 duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;

 (ii)

 duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;

 (iii)

 directors should not improperly fetter the exercise of future discretion;

 (iv)

 duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and

 (v)

 duty to exercise independent judgment.

 In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director has.

 As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the Amended Articles of Association, as amended, or alternatively by shareholder approval at general meetings.

 Accordingly, as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. In addition, conflicts of interest may arise when our board evaluates a particular business opportunity with respect to the above-listed criteria. We cannot assure you that any of the above mentioned conflicts will be resolved in our favor. Furthermore, each of our officers and directors currently has and may in the future have fiduciary obligations to other businesses, including other blank check companies similar to our company, of which they are now or may in the future be officers or directors. To the extent they identify business opportunities which may be suitable for the entities to which they owe fiduciary obligations, our officers and directors will honor those fiduciary obligations. Accordingly, it is possible they may not present opportunities to us that otherwise may be attractive to us unless the entities to which they owe fiduciary obligations and any successors to such entities have declined to accept such opportunities.

 In order to minimize potential conflicts of interest which may arise from multiple corporate affiliations, each of our officers and directors has contractually agreed, pursuant to a written agreement with us, until the earliest of a business combination, our liquidation or such time as he ceases to be an officer or director, to present to our company for our consideration, prior to presentation to any other entity, any suitable business opportunity which may reasonably be required to be presented to us, subject to any fiduciary or contractual obligations he might have.

 Below is a table summarizing the entities to which our officers and directors currently have fiduciary duties or contractual obligations which will take priority over us.

 Individual

 Entity

 Jiangping (Gary) Xiao

 Big Red Rooster Flow, LLC

 Mo Zhou

 Destone Acquisition Corp.

 Destone Holdings LLC

 To further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our initial shareholders, officers or directors unless we have obtained an opinion from an independent investment banking firm, or another independent entity that commonly renders valuation opinions, and the approval of a majority of our disinterested independent directors that the business combination is fair to our company (or shareholders) from a financial point of view. Notwithstanding the foregoing, our Amended Articles of Association, as amended, provides that, subject to fiduciary duties under Cayman Islands law, we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.

 Our officers and directors, as well as our initial shareholders, have agreed (i) to vote any shares owned by them in favor of any proposed business combination and (ii) not to redeem any shares in connection with a shareholder vote to approve a proposed initial business combination or any amendment to our charter documents prior to the consummation of our initial business combination or sell any shares to us in a tender offer in connection with a proposed initial business combination.

 Insider Trading Policy

 We have not adopted an insider trading policy.
Pursuant the letter agreements (the "Letter Agreements") dated August 9, 2022 entered by D. Boral, Embrace Change, sponsor,
the directors and officers of Embrace Change, transfer of the Company's shares owned by sponsor, the directors and officers of Embrace
Change shall not be made until the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the
date following the completion of an initial Business Combination on which Embrace Change completes a liquidation, merger, share exchange
or other similar transaction that results in all of Embrace Change's shareholders having the right to exchange their Ordinary Shares
for cash, securities or other property.

 Under the Letter Agreements, transfers are permitted
(a) to Embrace Change's officers or directors, any affiliates or family members of any of Embrace Change's officers or directors,
any members or partners of Sponsor, and D. Boral, or any of their affiliates or any employees of such affiliates; (b) in the case of an
individual, by gift to a member of one of the individual's immediate family or to a trust, the beneficiary of which is a member
of the individual's immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual,
by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified
domestic relations order; (e) by private sales or transfers made in connection with the consummation of a Business Combination at prices
no greater than the price at which Sponsor's Ordinary Shares, Private Securities or Ordinary Shares, as applicable, were originally
purchased; (f) by virtue of the Sponsor's or the D. Boral's organizational documents upon liquidation or dissolution of the
Sponsor or D. Boral, as applicable; (g) in the event of Embrace Change's liquidation prior to the completion of a Business Combination;
or (h) in the event of completion of a liquidation, merger, share exchange or other similar transaction which results in all of Embrace
Change's shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the
completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees
must enter into a written agreement agreeing to be bound by these Transfer restrictions and the other restrictions contained in the Letter
Agreements

 As a result of the foregoing, the Board did not
deem it necessary to adopt an insider trading policy at this time. We expect that in connection with the consummation of the initial business
combination that the post-business combination company will adopt an insider trading policy.

 Section 16(a) Beneficial Ownership Reporting Compliance

 Section 16(a) of the Exchange Act requires our executive officers, directors and persons who beneficially own more than 10% of a registered class of our equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of our ordinary shares and other equity securities. These executive officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons.

 Based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that all filing requirements applicable to our executive officers, directors and greater than 10% beneficial owners were filed in a timely manner.

 ITEM 11.

 Executive Compensation.

 Employment Agreements

 We have not entered into any employment agreements with our executive officers and have not made any agreements to provide benefits upon termination of employment.

 Executive Officers and Director Compensation

 No executive officer has received any cash compensation for services rendered to us and no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing stockholders, including our directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate, the consummation of a business combination. However, such individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no limit on the amount of these out-of-pocket expenses and there will be no review of the reasonableness of the expenses by anyone other than our board of directors and Audit Committee, which includes persons who may seek reimbursement, or a court of competent jurisdiction if such reimbursement is challenged.

 ITEM 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 The following
table sets forth as of March 11, 2025 the number of ordinary shares beneficially owned by (i) each person who is known by us to be
the beneficial owner of more than five percent of our issued and outstanding ordinary shares (ii) each of our officers and
directors; and (iii) all of our officers and directors as a group. As of March 11, 2025, we had 4,520,024 ordinary shares issued and
outstanding, including 4,123,027 ordinary shares and 396,997 ordinary shares underlying units.

 Unless otherwise indicated, we believe that all
persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following
table does not reflect record of beneficial ownership of any ordinary shares issuable upon exercise of the Rights, as the Rights are not
convertible within 60 days of March 11, 2025.

 Name and Address of Beneficial Owner (1)

 Amount and
Nature of
Beneficial
Ownership of
Common Stock

 Approximate
Percentage of
Outstanding
Shares of
Common Stock

 Jingyu Wang

 -

 -

 Zheng Yuan

 -

 -

 Jiangping (Gary) Xiao

 -

 -

 Hang Zhou

 -

 -

 Zhou Mo

 -

 -

 All current directors and executive officers as a group (five individuals)

 -

 -

 Wuren Fubao Inc. (2)

 2,221,964

 49.2
 %

 Mizuho Financial Group, Inc. (3)

 405,828

 9.0
 %

 Wolverine Asset Management, LLC (4)

 466,542

 10.3
 %

 Polar Asset Management Partners Inc. (5)

 250,000

 5.5
 %

 TD SECURITIES (USA) LLC (6)

 240,719

 5.3
 %

 Glazer Capital, LLC (7)

 230,000

 5.1
 %

 (1)

 Unless otherwise indicated, the business address of each of the individuals is 5186 Carroll Canyon Rd, San Diego, CA 92121.

 (2)

 Represents shares held by our sponsor. Mr. Bin Li has voting and dispositive power over the shares held of record by our sponsor. Mr. Bin Li disclaims any beneficial ownership of the shares held by our sponsor, except to the extent of his pecuniary interest therein.

 (3)

 Based on information provided in a Schedule 13G/A filed on February 13, 2025. Mizuho Financial Group, Inc., Mizuho Bank, Ltd. and Mizuho
Americas LLC may be deemed to be indirect beneficial owners of said equity securities directly held by Mizuho Securities USA LLC which
is their wholly-owned subsidiary. The address of the principal office of the reporting person is 1–5–5, Otemachi, Chiyoda–ku,
Tokyo 100–8176, Japan.

 (4)

 Based on information provided in a Schedule 13G filed by Wolverine Asset Management, LLC, Wolverine Holdings, L.P., Wolverine Trading Partners, Inc., Christopher L. Gust and Robert R. Bellick on February 8, 2024. Wolverine Asset Management, LLC ("WAM") is an investment adviser and has voting and disposition power over 466,542 of the Issuer's Ordinary Shares. The sole member and manager of WAM is Wolverine Holdings, L.P. ("Wolverine Holdings"). Robert R. Bellick and Christopher L. Gust may be deemed to control Wolverine Trading Partners, Inc. ("WTP"), the general partner of Wolverine Holdings. Each of Wolverine Holdings, Mr. Bellick, Mr. Gust, and WTP have voting and disposition power over 466,742 of Embrace Change's Ordinary Shares. The address of the principal office of the reporting persons is c/o Wolverine Asset Management, LLC, 175 West Jackson Boulevard, Suite 340, Chicago, IL 60604.

 (5)

 Based on information provided in a Schedule 13G filed on February 14, 2025. The address of the principal office of the reporting person is 16 York Street, Suite 2900, Toronto, Ontario, M5J 0E6.

 (6)

 Based on information provided in a Schedule 13G filed on February 13, 2025. The address of TD Securities (USA) LLC's ("TDS") principal office and Toronto Dominion Holdings (U.S.A.), Inc.'s ("TDH") principal office is One Vanderbilt Avenue, New York, New York 10017. The address of TD Group US Holdings LLC's ("TD GUS") principal office is 251 Little Falls Drive, Wellington, Delaware 19808. The address of Toronto Dominion Bank's ("TD Bank") principal office is Toronto-Dominion Centre, 66 Wellington Street West, 12th Floor, TD Tower, Toronto, Ontario, Canada M5K 1A2. TDS has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of these shares.

 (7)

 Based on information provided in a Schedule 13G filed on November 14, 2024. This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The address of the business office of each of the reporting persons is 250 West 55th Street, Suite 30A, New York, New York 10019.

 ITEM 13.

 Certain Relationships and Related Transactions, and Director Independence.

 Prior to our IPO, we issued an aggregate of 1,437,500 ordinary shares to certain of our initial shareholders. We subsequently declared a share dividend of 0.50 shares for each outstanding share, resulting in 2,156,250 founder shares being outstanding. On July 1, 2022, the sponsor surrendered an aggregate of 287,500 founder shares for no consideration, resulting in 1,868,750 shares being outstanding. On August 12, 2022, as a result of the partial exercise of the Representative's Over-Allotment Option, an aggregate of 20,536 founder shares were further forfeited to the Company, which surrender was effective retroactively and resulting in 1,848,214 shares being outstanding and held by Sponsor. As of December 31, 2024, there were 1,848,214 founder shares issued and outstanding. The aggregate purchase price for the founder shares was $25,000, or approximately $0.014 per share.

 Subject to certain limited exceptions, our initial shareholders have agreed not to transfer, assign or sell their founder shares until six months after the date of the consummation of our initial business combination or earlier if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property.

 Simultaneous with the consummation of the IPO on August 12, 2022, we consummated the private placement ("Private Placement") with the sponsor of 373,750 units (the "Private Units"), generating total proceeds of $3,737,500. The Private Units are identical to the Units sold in the IPO except that the holder has agreed not to transfer, assign, or sell any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until the completion of the Company's initial business combination. In addition, the warrants included in the Private Units are not redeemable if held by them or a permitted transferee. The sponsor was granted certain demand and piggy-back registration rights in connection with the purchase of the Private Units. Our sponsor has agreed not to transfer, assign or sell any of the private units and underlying ordinary shares, warrants or rights until after the completion of our initial business combination.

 We have entered into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our Amended Articles of Association, as amended.

 We currently maintain our executive offices at
5186 Carroll Canyon Rd, San Diego, CA 92121. Such space is provided to us free of charge by our sponsor.

 Other than reimbursement of any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations, no compensation or fees of any kind, including finder's fees, consulting fees or other similar compensation, will be paid to our sponsor, officers or directors, or to any of their respective affiliates, prior to or with respect to our initial business combination (regardless of the type of transaction that it is). Our independent directors will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates and will be responsible for reviewing and approving all related party transactions as defined under Item 404 of Regulation S-K, after reviewing each such transaction for potential conflicts of interests and other improprieties.

 In order to finance transaction costs in connection with an intended initial business combination, our initial shareholders, officers and directors and their affiliates may, but are not obligated to, loan us funds as may be required. Such loans would be evidenced by promissory notes. In the event that we are unable to consummate an initial business combination, we may use a portion of the offering proceeds held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. If we consummate an initial business combination, the notes would either be paid upon consummation of our initial business combination, without interest, or, at the lender's discretion, up to $500,000 of the notes may be converted upon consummation of our business combination into additional private units at a price of $10.00 per unit (which, for example, would result in the holders being issued 50,000 units if the full amount of notes are issued and converted).

 After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a general meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.

 On September 8, 2023, the Company issued an unsecured promissory note, effective as of September 8, 2023, in an amount of $10,000 to the Sponsor. This note bears no interest and is repayable in full upon the consummation of the Company's business combination. It is convertible at the Sponsor's election upon the consummation of the Company's business combination. Upon such election, the note will convert, at a price of $10.00 per unit, into units identical to the private placement units issued in connection with the Company's Initial Public Offering.

 On each of October 10, 2023, November 8,
2023 and December 14, 2023, the Company issued an unsecured promissory note (each is called "October 2023 Convertible
Note", "November 2023 Convertible Note" and "December 2023 Convertible Note", respectively, collectively
with September 2023 Convertible Note were called "Convertible Promissory Notes") amounting to $100,000, $190,112 and
$100,000, respectively, for an aggregated of $390,112, to the Company's CFO. From January 1, 2024 to December 31, 2024,
the Company issued five unsecured promissory notes (together with the convertible promissory notes as described above, were called "Convertible
Promissory Notes") amounting to $100,000, $100,000, $100,000, $70,000 and $81,000, respectively, for an aggregated of $451,000,
to the Company's CFO. The Convertible Promissory Notes bear no interest and are repayable in full upon the consummation of the Company's
Business Combination. Up to $500,000 of the convertible Promissory Notes are convertible at the CFO's election upon the consummation
of the Company's Business Combination. Upon such election, the notes will convert, at a price of $10.00 per unit, into units identical
to the private placement units issued in connection with the Company's Initial Public Offering.

 In addition, from October 2023 to
December 2024, the CFO paid off certain bills with an aggregated amount of $144,060 for the Company without issuance of any promissory
notes. These amounts were unsecured, non-interesting bearing and will be payable as demanded. The Company recorded these amounts as due
to related party on the balance sheet.

 All ongoing and future transactions between us and any member of our management team or his or her respective affiliates will be on terms believed by us at that time, based upon other similar arrangements known to us, to be no less favorable to us than are available from unaffiliated third parties. It is our intention to obtain estimates from unaffiliated third parties for similar goods or services to ascertain whether such transactions with affiliates are on terms that are no less favorable to us than are otherwise available from such unaffiliated third parties. If a transaction with an affiliated third party were found to be on terms less favorable to us than with an unaffiliated third party, we would not engage in such transaction.

 We are not prohibited from pursuing an initial business combination with a company that is affiliated with our initial shareholders, officers or directors. In the event we seek to complete our initial business combination with a target that is affiliated with our initial shareholders, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that our initial business combination is fair to our company (or shareholders) from a financial point of view.

 Director Independence

 Nasdaq listing standards require that a majority of our board of directors be independent. For a description of the director independence, see above Part III, Item 10 - Directors, Executive Officers and Corporate Governance.

 ITEM 14.

 Principal Accountant Fees and Services.

 The firm of MaloneBailey, LLP, or MaloneBailey, acts as our independent registered public accounting firm. The following is a summary of fees paid to MaloneBailey for services rendered.

 Audit Fees. For the year ended December
31, 2023, fees for our independent registered public accounting firm were $61,500 for the services MaloneBailey performed in connection
with the review of the financial information included in our Forms 10-Q for the respective periods and audit of our December 31, 2023
financial statements included in this Annual Report on Form 10-K. For the year ended December 31, 2024, fees for our independent registered
public accounting firm were $103,000 for the services MaloneBailey performed in connection with the review of the financial information
included in our Forms 10-Q for the respective periods and audit of our December 31, 2024 financial statements included in this Annual
Report on Form 10-K.

 Audit-Related Fees. For the year ended
December 31, 2024 and 2023, our independent registered public accounting firm did not render assurance and related services related to
the performance of the audit or review of financial statements.

 Tax Fees. For the year ended December 31,
2024 and 2023, our independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax
planning.

 All Other Fees. For the year ended December
31, 2024 and 2023, there were no fees billed for products and services provided by our independent registered public accounting firm other
than those set forth above.

 Pre-Approval Policy

 Our Audit Committee was formed upon the consummation of our IPO. As a result, the Audit Committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our Audit Committee were approved by our board of directors. Since the formation of our Audit Committee, and on a going-forward basis, the Audit Committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the Audit Committee prior to the completion of the audit).

 ITEM 15.

 Exhibits, Financial Statement Schedules

 (a)

 The following documents are filed as part of this Form 10-K:

 (1)

 Financial Statements:

 INDEX TO AUDITED FINANCIAL STATEMENTS

 Report of Independent Registered Public Accounting Firm (PCAOB ID No: 206)

 Audited Financial Statements:

 Balance Sheets as of December 31, 2024 and 2023

 Statements of Operations for the years ended December 31, 2024 and 2023

 Statements of Changes in Stockholders' Deficit for the years ended December 31, 2024 and 2023

 Statements of Cash Flows for the years ended December 31, 2024 and 2023

 Notes to Financial Statements

 F-8 – F-21

 F- 1

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To the Shareholders and Board of Directors of

 Embrace Change Acquisition Corp.

 Opinion on the Financial Statements

 We have audited the accompanying balance sheets of Embrace Change Acquisition
Corp. (the "Company") as of December 31, 2024 and 2023, and the related statements of operations, changes in stockholders'
deficit, and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles
generally accepted in the United States of America.

 Going Concern Matter

 The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company's business plan is
dependent on the completion of a business combination within a prescribed period of time and if not completed will cease all operations
except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raises substantial doubt about the
Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note
1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 Basis for Opinion

 These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to
be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.

 We conducted our audits in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over
financial reporting. Accordingly, we express no such opinion.

 Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 /s/ MaloneBailey, LLP

 www.malonebailey.com

 We have served as the Company's auditor since 2021.

 Houston, Texas

 F- 2

 BALANCE SHEETS

 2024

 2023

 ASSETS

 Cash

 $

 66,985

 $

 5,308

 Total Current Assets

 66,985

 5,308

 Investments held in trust account

 26,087,209

 56,231,052

 Total Assets

 $

 26,154,194

 $

 56,236,360

 LIABILITIES AND STOCKHOLDERS' DEFICIT

 Current Liabilities

 Accounts payable and accrued expenses

 $

 1,100,072

 $

 1,077,258

 Due to related party

 144,060

 54,535

 Due to third party

 775,000

 -

 Convertible promissory note – related party

 851,112

 400,112

 Promissory note
 – third party

 54,664

 -

 Total Current Liabilities

 2,924,908

 1,531,905

 Deferred underwriter fee payable

 2,966,000

 2,587,499

 Total Liabilities

 5,890,908

 4,119,404

 Commitments and Contingencies (Note 6)

 Ordinary shares subject to possible redemption, 2,224,131 and 5,127,282 shares issued and outstanding at redemption value of $ 11.73 per
share and $ 10.97 per share as of December 31, 2024 and December 31, 2023, respectively

 26,087,209

 56,231,052

 Stockholders' Deficit

 Ordinary Shares, par value $ 0.0001; 500,000,000 shares authorized; 2,295,893 (excluding 2,224,131 and 5,127,282 shares subject to redemption,
respectively) issued and outstanding as of December 31, 2024 and December 31, 2023, respectively

 Accumulated deficit

 ( 5,824,153

)

 ( 4,114,326

)

 Total Stockholders' Deficit

 ( 5,823,923

)

 ( 4,114,096

)

 Total Liabilities and Stockholders' Deficit

 $

 26,154,194

 $

 56,236,360

 F- 3

 STATEMENTS OF OPERATIONS

 2024

 2023

 Formation and operating costs

 $

 ( 551,662

)

 $

 ( 1,062,206

)

 Loss from operations

 ( 551,662

)

 ( 1,062,206

)

 Other income (loss):

 Investment income earned on investments held in Trust Account

 2,377,420

 3,486,597

 Loss on modification of deferred underwriting commission

 ( 378,501

)

 -

 Interest expense

 ( 4,664

)

 -

 Total other
 income

 1,994,255

 3,486,597

 $

 $

 Weighted average shares outstanding, basic and diluted

 6,368,204

 9,014,565

 Basic and diluted net income per ordinary share

 $

 0.23

 $

 0.27

 F- 4

 STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

 FOR THE YEAR ENDED DECEMBER 31, 2024

 Additional

 Total

 Ordinary shares

 Paid in

 Accumulated

 Stockholders'

 Shares

 Amount

 Capital

 Deficit

 Deficit

 Balance – December 31, 2023

 2,295,893

 $

 $

 -

 $

 ( 4,114,326

)

 $

 ( 4,114,096

)

 Amount deposited into trust account subject to redemption

 -

 -

 -

 ( 775,000

)

 ( 775,000

)

 Re-measurement of ordinary shares subject to redemption

 -

 -

 -

 ( 2,377,420

)

 ( 2,377,420

)

 -

 -

 -

 Balance
 – December 31, 2024

 2,295,893

 $

 $

 -

 $

 ( 5,824,153

)

 $

 ( 5,823,923

)

 F- 5

 STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

 FOR THE YEAR ENDED DECEMBER 31, 2023

 Additional

 Total

 Ordinary shares

 Paid in

 Accumulated

 Stockholders'

 Shares

 Amount

 Capital

 Deficit

 Deficit

 Balance – December 31, 2022

 2,295,893

 $

 $

 -

 $

 ( 2,341,247

)

 $

 ( 2,341,017

)

 Re-measurement of ordinary shares
 subject to redemption

 -

 -

 -

 ( 3,486,597

)

 ( 3,486,597

)

 Accretion of offering costs to deficit

 -

 -

 -

 ( 210,873

)

 ( 210,873

)

 Amount deposited into trust account subject to redemption

 -

 -

 -

 ( 500,000

)

 ( 500,000

)

 -

 -

 -

 Balance – December 31, 2023

 2,295,893

 $

 $

 -

 $

 ( 4,114,326

)

 $

 ( 4,114,096

)

 F- 6

 STATEMENTS OF CASH FLOWS

 2024

 year ended December 31,
 2023

 Cash flow from operating activities:

 $

 $

 Adjustments to reconcile net income to net cash used in operating activities:

 Investment income earned on investments held in Trust Account

 ( 2,377,420

)

 ( 3,486,597

)

 Loss on modification of deferred underwriting commission

 378,501

 -

 Interest expense

 4,664

 -

 Changes in operating assets and liabilities:

 Other receivables

 -

 Accounts payable and accrued expenses

 22,814

 709,334

 Net cash used in operating activities

 ( 528,848

)

 ( 352,351

)

 Cash flows from investing activities:

 Investment
 of cash in Trust Account

 ( 775,000

)

 ( 500,000

)

 Cash withdrawn
 from Trust Account in connection with redemption

 33,296,263

 24,296,998

 Net cash provided by investing activities

 32,521,263

 23,796,998

 Cash flow from financing activities:

 Proceeds from convertible promissory note - related party

 451,000

 400,112

 Proceeds from promissory note - third party

 300,000

 -

 Proceeds from related party for working capital purpose

 89,525

 54,535

 Proceeds from third party for working capital purpose

 775,000

 -

 Redemption of ordinary shares

 ( 33,296,263

)

 ( 24,296,998

)

 Repayment of promissory note - third party

 ( 250,000

)

 -

 Net cash used in financing activities

 ( 31,930,738

)

 ( 23,842,351

)

 Net change in cash

 61,677

 ( 397,704

)

 Cash at the beginning of the period

 5,308

 403,012

 Cash at the end of the period

 $

 66,985

 $

 5,308

 Supplemental disclosure of non-cash financing activities:

 Accretion of offering costs to deficit

 $

 -

 $

 210,873

 Re-measurement of ordinary shares subject to redemption (1)

 $

 2,377,420

 $

 3,486,597

 Extension funds attributable to ordinary shares subject to redemption

 $

 775,000

 $

 500,000

 Deferred underwriting fee payable

 $

 378,501

 $

 -

 (1)

 The value of ordinary share subject to redemption was re-measured with investment income earned on investments held in Trust Account.

 F- 7

 NOTES TO FINANCIAL STATEMENTS

 NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN

 Embrace Change Acquisition Corp. (the "Company") is a blank check company incorporated in the Cayman Islands on March 3, 2021. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities ("Business Combination"). The Company may pursue a business combination target in any business or industry.

 As of December 31, 2024, the Company had not yet commenced any operations. All activity through December 31, 2024 relates to the Company's formation, the Initial Public Offering (as defined below) and after the Initial Public Offering, searching for a Business Combination target. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO (as defined below). The Company has selected December 31 as its fiscal year end. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 The Company's sponsor is Wuren Fubao Inc., a Cayman Islands exempted company (the "Sponsor"). The registration statement for the Company's Initial Public Offering was declared effective on August 9, 2022. On August 12, 2022, the Company consummated its Initial Public Offering of 7,392,855 units (the "Units", and, with respect to the ordinary shares included in the Units being offered, the "Public Shares"), including the issuance of 892,855 Units as a result of the partial exercise by EF Hutton, division of Benchmark Investments, LLC (the "Representative") of its over-allotment option (the "Over-Allotment Option"), at $ 10.00 per Unit, generating gross proceeds of $ 73,928,550 (the "Initial Public Offering" or "IPO"), and incurring offering costs of $ 3,898,030, of which $ 2,587,499 was for deferred underwriting commissions (see Note 6). As a result of the partial exercise of the Representative's Over-Allotment Option, an aggregate of 20,536 founder shares were forfeited to the Company of which was reflected retroactively.

 Simultaneously with the closing of the IPO, the Company consummated the private placement ("Private Placement") with the Sponsor of 373,750 units (the "Private Units"), generating total proceeds of $ 3,737,500 (see Note 4).

 Following the closing of the Initial Public Offering on August 12, 2022, an amount of $ 75,776,764 ($ 10.25 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and a portion of the proceeds from the sale of the Private Units was placed in a trust account (the "Trust Account") and may be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company's shareholders, as described below.

 The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a business combination only if the Company have net tangible assets of at least $ 5,000,001 immediately prior to or upon such consummation and, solely if a vote is held to approve a business combination, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company.

 F- 8

 The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $ 10.25 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company's warrants. These ordinary shares were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity."

 If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

 The Sponsor has agreed (a) to vote its founder shares, the ordinary shares included in the Private Units (the "Private Shares") and any Public Shares purchased during or after the IPO in favor of a Business Combination, (b) not to propose an amendment to the Company's Memorandum and Articles of Association with respect to the Company's pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Ordinary shares) and Private Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Memorandum and Articles of Association relating to shareholders' rights of pre-Business Combination activity and (d) that the Ordinary shares and Private Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the IPO if the Company fails to complete its Business Combination.

 On August 9, 2023, the Company held an
extraordinary general meeting of shareholders (the "First Extraordinary General Meeting"), at which the Company's
shareholders approved the following proposals: (a) as a special resolution, giving the Company the right to extend the date by which
the Company must
consummate a business combination (the "Combination Period") twelve (12) times for an additional one (1) month each
time, from August 12, 2023 (i.e. the end of 12 months from the consummation of its Initial Public Offering, the
"Termination Date") to August 12, 2024, by depositing into the Trust Account the lesser of
$ 100,000
or $ 0.045
per outstanding public share for each one-month extension (the "Initial Extension Payment") (the "First Extension
Amendment Proposal") by deleting the amended and restated memorandum and articles of association (the "Articles of
Association") in its entirety and substitute it with the second amended and restated memorandum and articles of association of
the Company (the "Amended Articles of Association"); (b) as an ordinary resolution, an amendment to the investment
management trust agreement dated as of August 9, 2022 (the "Trust Agreement") between the Company and Continental
Stock Transfer & Trust Company (the "Trustee"), to extend the Combination Period from the Termination Date to the
August 12, 2024, by depositing into the Trust Agreement the Initial Extension Payment (the "First Trust Agreement
Amendment Proposal"); and (c) as a special resolution, an amendment to the Articles of Association to remove the net tangible
asset requirement from the Articles of Association in order to expand the methods that the Company may employ so as not to become
subject to the "penny stock" rules of the Securities and Exchange Commission by deleting the Articles of Association in
its entirety and substitute it with the second amended and restated memorandum and articles of association of the Company (the
"NTA Requirement Amendment Proposal"). In connection with the shareholders' vote at the First Extraordinary
General Meeting, 1,550,710
ordinary shares were tendered for redemption. On August 14, 2023, the Company accepted a reversal request for 109,819
shares. As a result, a total of 1,440,891
ordinary shares were redeemed at a redemption price of approximately $ 10.68
per share, for an aggregate redemption amount of $ 15,385,924,
leaving 5,951,964
ordinary shares subject to possible redemption still outstanding after the August 2023 redemption.

 In connection with the shareholders' vote
at the annual general meeting ("Annual General Meeting") of shareholders held by the Company on October 20, 2023, 824,682
ordinary shares were tendered for redemption, leaving 5,127,282
ordinary shares subject to possible redemption still outstanding after the October 2023 redemption.

 F- 9

 From
August 2023 to December 2023, the Company deposited five tranches of $100,000, for an aggregated of $500,000 into the
Trust Account, extending the Termination Date to January 12, 2024. From January 2024 to August 2024, the Company
deposited additional seven tranches of $100,000, for an aggregated of $700,000 into the Trust Account, extending the Termination
Date to August 12, 2024.

 On August 12, 2024, the Company held an extraordinary
general meeting of shareholders (the "Second Extraordinary General Meeting"), at which, the Company and its Trustee signed
an amendment to the investment management Trust Agreement, to give the Company the right to extend the Combination Period twelve (12)
times for an additional one (1) month each time, from August 12, 2024 to August 12, 2025 (the "Extended Date"), by depositing
into the Trust Account $ 75,000 for each one-month extension (the "Amended Extension Payment"), as approved by the Company's
shareholders in accordance with the Company's Amended Articles of Association. At the Second Extraordinary General Meeting, the
shareholders of the Company approved a special resolution to the Amended Articles of Association to extend the Combination Period from
the Termination Date to the Extended Date and to delete words "(less up to US$ 50,000 of interest to pay dissolution expenses)".

 In connection with the shareholders' vote
at the Second Extraordinary General Meeting held by the Company on August 12, 2024, 2,903,151 ordinary shares were tendered for redemption,
leaving 2,224,131 ordinary shares subject to possible redemption still outstanding after the August 2024 redemption.

 On September 10,
2024, the Company deposited $ 75,000 into the Trust Account, extending the Termination Date to September 12, 2024. The Company has the
right to extend the Combination Period eleven (11) more times for an additional one (1) month each time, from September 12, 2024
to August 12, 2025. Up to the date the financial statements were issued, there was no additional deposits made other than the payment that was made on September 10, 2024. The Company is obligated to deposit another six tranches
of $ 75,000, for an aggregate of 450,000, to the Trust Account, to extend the date that the
Company has to consummate a business combination to March 12, 2025.

 If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable, if
any), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders' rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company's board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

 The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.25 per share, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company's indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company's independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 F- 10

 Business Combination Agreement

 On January 26, 2025, the Company entered into
a merger agreement (as it may be amended, supplemented, or otherwise modified from time to time, the "Merger Agreement"),
by and between the Company, EMC Merger Sub 1, a Cayman Islands exempted company and wholly owned subsidiary of the Company ("Purchaser"),
incorporated on January 9, 2025, EMC Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of Purchaser ("Merger
Sub"), incorporated on January 9, 2025, and Tianji Tire Global (Cayman) Limited, a Cayman Islands exempted company ("Tianji"),
pursuant to which (a) the Company will be merged with and into Purchaser (the "Reincorporation Merger"), with Purchaser surviving
the Reincorporation Merger, and (b) Merger Sub will be merged with and into Tianji (the "Acquisition Merger"), with Tianji
surviving the Acquisition Merger as a direct wholly owned subsidiary of Purchaser (collectively, the "Business Combination").
Following the Business Combination, Purchaser will be a publicly traded company.

 Consideration

 At the effective time of the Acquisition Merger,
each Tianji Class A ordinary share will be converted into the right to receive one Reincorporation Merger Surviving Corporation Class
A ordinary share and each Tianji Class B ordinary share will be converted into the right to receive one Reincorporation Merger Surviving
Corporation Class B ordinary share, as outlined in the Merger Agreement.

 Purchaser will issue an aggregate of 45,000,000
of its ordinary shares ("Purchaser Ordinary Shares") with a deemed price per share of US$ 10.00, for a total value equal to
the merger consideration, $ 450,000,000 (the "Merger Consideration Shares"), to the shareholders of Tianji (the "Tianji
Shareholders") at the Business Combination closing (the "Closing"). Upon Closing, the Tianji Shareholders will no longer
hold any rights in the Tianji ordinary shares they held prior to the Closing, and they will hold the right to receive their portion of
the Merger Consideration Shares pursuant to the Merger Agreement.

 Issuance of Share Consideration

 In connection with the Acquisition Merger, fractional
shares of the Purchaser Ordinary Shares that would otherwise be issued to the Tianji Shareholders will be rounded down to the nearest
whole share.

 Liquidity and Capital Resources

 As of December 31, 2024, the Company had $ 66,985 of cash in its operating bank account.

 The Company's liquidity needs prior to the
consummation of the Initial Public Offering were satisfied through the payment of $ 25,000
from the Sponsor to cover for certain offering costs on the Company's behalf in exchange for issuance of Founder Shares (as
defined in Note 5), and loan from the Sponsor of $ 159,478
under the promissory note, which has been terminated upon closing of the Initial Public Offering. Subsequent to the consummation of
the Initial Public Offering, the Company's liquidity has been satisfied through the net proceeds from the consummation of the
Initial Public Offering, the Private Placement held outside of the Trust Account, the Convertible Promissory Notes (as defined and
described in Note 5), the amount due to third party which is defined and described in Note 6 and the promissory note - third party
which is defined and described in Note 7. As of December 31, 2024, there was $ 851,112
outstanding under the Convertible Promissory Notes, which was issued to the Company's related party for extension and working
capital purposes, $ 144,060 due to related party for working capital purposes, $ 54,664 outstanding under the promissory note - third
party, which was issued for working capital purpose and $ 775,000 due to third party for extension purposes.

 F- 11

 Going Concern Consideration

 The Company expects to incur significant costs
in pursuit of its financing and acquisition plans. In connection with the Company's assessment of going concern considerations in
accordance with Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability
to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an Initial Business
Combination by August 12, 2025 (subject to the Amended Extension Payment is made as required for each monthly extension), the requirement
that the Company cease all operations, redeem the Public Shares and thereafter liquidate and dissolve raises substantial doubt about the
Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the
outcome of this uncertainty. The accompanying financial statement has been prepared in conformity with generally accepted accounting principles
in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern.

 NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 Basis of Presentation

 The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the SEC.

 Use of Estimates

 The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during
the reporting period.

 Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 Emerging Growth Company

 The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 F- 12

 Cash and Cash Equivalents

 The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $ 66,985 and $ 5,308, respectively,
in cash outside of trust account as of December 31, 2024 and 2023. The Company had no cash equivalents as of December 31, 2024
and 2023.

 Investments Held in Trust Account

 As of December 31, 2024 and 2023, substantially
all of the assets held in the Trust Account were held in U.S. Treasury Bills. All of the Company's investments
held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at
the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included
in investment income earned on investments held in Trust in the accompanying statements of operations. The estimated fair values of investments
held in Trust Account are determined using available market information. As of December 31, 2024 and 2023, the estimated fair values
of investments held in Trust Account was $ 26,087,209 and $ 56,231,052, respectively.

 Fair Value of Financial Instruments

 The fair value of the Company's assets and liabilities, which
qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures," approximates the carrying
amounts represented in the accompanying balance sheets, primarily due to their short-term nature.

 The Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 The following table presents information about the Company's assets that are measured at fair value on a recurring basis as of December 31, 2024 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

 Summary of Fair Value, Assets Measured on Recurring Basis

 Description

 Quoted Prices in
Active Markets
(Level 1)

 Significant other
Observable
Inputs

 (Level 2)

 Significant other
Unobservable
Inputs

 (Level 3)

 Assets

 Investments held in trust account

 $

 26,087,209

 $

 -

 $

 -

 F- 13

 The following table presents information about the Company's assets that are measured at fair value on a recurring basis as of December 31, 2023 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value:

 Description

 Quoted Prices in
Active Markets
(Level 1)

 Significant other
Observable
Inputs

 (Level 2)

 Significant other
Unobservable
Inputs

 (Level 3)

 Assets

 Investments held in trust account

 $

 56,231,052

 $

 -

 $

 -

 Offering Costs Associated with the Initial Public Offering

 Offering costs consisted of legal, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. With the partial exercise of the over-allotment, offering cost amounted to $ 3,898,030 consisting of $ 739,286 of up-front underwriting fees and a deferred discount of $ 2,587,499 and $ 571,245 of other costs, were charged to additional paid-in capital upon completion of the Public Offering.

 For the year ended December 31, 2023, the Company charged $ 210,873 in offering costs to accumulated deficit.

 Ordinary Shares Subject to Possible Redemption

 As discussed in Note 3, all of the 7,392,855 ordinary
shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public
Shares in connection with the Company's liquidation, if there is a stockholder vote or tender offer in connection with the Business
Combination and in connection with certain amendments to the Company's amended and restated certificate of incorporation. In accordance
with ASC 480, conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control)
are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity's
equity instruments, are excluded from the provisions of ASC 480. In connection with the shareholders' vote at the Extraordinary
General Meeting on August 9, 2023, 1,550,710 ordinary shares were tendered for redemption. On August 14, 2023, the Company accepted
a reversal request for 109,819 shares. As a result, a total of 1,440,891 ordinary shares were redeemed, leaving 5,951,964 ordinary shares
subject to possible redemption after the August 7, 2023 redemption. In connection with the Annual General Meeting held on October 20,
2023, 824,682 ordinary shares were tendered for redemption, leaving 5,127,282 ordinary shares subject to possible redemption still outstanding.
In connection with the shareholders' vote at the Extraordinary General Meeting of shareholders held by the Company on August 12,
2024, 2,903,151 ordinary shares were redeemed, leaving 2,224,131 ordinary shares subject to possible redemption after the August 12, 2024
redemption.

 Accordingly, as of December 31, 2024 and
2023, 2,224,131 and 5,127,282 ordinary shares, respectively, subject to possible redemption at the redemption amount were presented at
redemption value as temporary equity, outside of the stockholders' deficit section of the Company's balance sheets.

 Income Taxes

 The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. The Company's management determined that the Cayman Islands is the Company's major tax
jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax
expense. There were no
unrecognized tax benefits as of December 31, 2024 and 2023 and no
amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position.

 The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company's tax provision was zero from inception to December 31, 2024.

 F- 14

 Segment Reporting

 ASC Topic 280, "Segment Reporting,"
establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic
areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information
is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how to allocate
resources and assess performance.

 The Company's chief operating decision maker
has been identified as the Chief Executive Officer ("CODM"), who reviews the operating results for the Company as a whole
to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company
only has one operating segment.

 When evaluating the Company's performance
and making key decisions regarding resource allocation, the CODM reviews several key metrics, formation and operational costs and interest
earned on investments held in Trust Account which include the accompanying statements of operations.

 The key measures of segment profit or loss reviewed
by our CODM are interest earned on investments held in Trust Account and formation and operational costs. The CODM reviews interest earned
on investments held in Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment
with the Trust Account funds while maintaining compliance with the trust agreement. Formation and operational costs are reviewed and
monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the
business combination period. The CODM also reviews formation and operational costs to manage, maintain and enforce all contractual agreements
to ensure costs are aligned with all agreements and budget.

 Recent Accounting Pronouncements

 In November 2023, the FASB issued ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual
and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker ("CODM"),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide
all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal
years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption
permitted. The Company adopted ASU 2023 - 07 in the fiscal year 2024 and there was no significant impact.

 Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's financial statements.

 Concentration of Credit Risk

 Financial instruments that potentially subject
the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal
depository insurance coverage of $ 250,000. As of December 31, 2024, the Company had not experienced losses on this account and management
believes the Company is not exposed to significant risks on such account. As of December 31, 2024 and 2023, the Company had $ 66,985
and $ 5,308 cash, respectively, held in operating bank account.

 Net Income Per Share

 Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the "Private Warrants") since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted income per share is the same as basic income per share for the periods.

 F- 15

 The following table reflects the calculation of basic and diluted net income per ordinary share:

 Schedule of Basic and Diluted Net income Per Share

 Summary of Basic and Diluted Net Loss Per Share

 2024

 2023

 $

 $

 Denominator: weighted average number of ordinary shares

 6,368,204

 9,014,565

 Basic and diluted net income per ordinary share

 $

 0.23

 $

 0.27

 Risks and Uncertainties

 As a result of the military action commenced in
February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company's ability
to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business
Combination, may be materially and adversely affected. In addition, the Company's ability to consummate a transaction may be dependent
on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility,
or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this
action and related sanctions on the world economy and the specific impact on the Company's financial position, results of operations
and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.

 NOTE 3. INITIAL PUBLIC OFFERING

 On August 12, 2022, the Company consummated its Initial Public Offering of 7,392,855 Units (including the issuance of 892,855 Units as a result of the underwriter's partial exercise of its over-allotment option), at $ 10.00 per Unit, generating gross proceeds of $ 73,928,550.

 Each Unit consists of one ordinary share, one warrant and one right. Each whole warrant entitles the holder thereof to purchase one ordinary share at a price of $ 11.50 per share, subject to adjustment as described in the IPO prospectus. Each right entitles the holder thereof to acquire one-eighth of one ordinary share (see Note 7).

 As of August 12, 2022, the Company incurred offering costs of approximately $ 3,898,030, of which $ 2,587,499 was for deferred underwriting commissions. For the year ended December 31, 2023, the Company recorded $ 210,873 in offering costs and charged it to accumulated deficit.

 NOTE 4. PRIVATE PLACEMENT

 Simultaneously with the closing of the IPO, the Company consummated the private placement ("Private Placement") with the Sponsor of 373,750 units (the "Private Units"), generating total proceeds of $ 3,737,500.

 The proceeds from the sale of the Private Units were added to the net proceeds from the Offering held in the Trust Account. The Private Units are identical to the Units sold in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the Company's trust account with respect to the private shares, which will expire worthless if the Company does not consummate a business combination. With respect to the private warrants ("Private Warrants"), as described in Note 7, the warrant agent shall not register any transfer of private warrants until after the consummation of an initial business. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Warrants will expire worthless.

 F- 16

 NOTE 5. RELATED PARTY TRANSACTIONS

 Founder Shares

 During the period ended December 31, 2021, the Company issued an aggregate of 2,156,250 shares of Ordinary shares to the Sponsor for an aggregate purchase price of $ 25,000 in cash. On July 1, 2022, the sponsor surrendered an aggregate of 287,500 founder shares for no consideration, which surrender was effective retroactively, resulting in 1,868,750 shares being outstanding. On August 12, 2022, as a result of the partial exercise of the Representative's Over-Allotment Option, an aggregate of 20,536 founder shares were further forfeited to the Company, which surrender was effective retroactively and resulting in 1,848,214 shares being outstanding, so that the Sponsor will collectively own 20 % of the Company's issued and outstanding shares after IPO (assuming the initial shareholders do not purchase any Public Shares in the IPO and excluding the Private Units and underlying securities).

 Subject to certain limited exceptions, the initial shareholders have agreed not to transfer, assign or sell their founder shares until six months after the date of the consummation of our Business Combination or earlier if, subsequent to Business Combination, the Company consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property.

 Due to Related Party

 As of December 31, 2024 and 2023, the amounts
due to related party was $ 144,060 and $ 54,535, respectively, for expenses paid by CFO on behalf of the Company. These amounts are unsecured,
non-interest bearing and due on demand.

 Convertible Promissory Notes - Related Party

 On September 8, 2023, the Company issued an unsecured promissory note (the "September 2023 Convertible Note"), effective as of September 8, 2023, in an amount of $ 10,000 to the Sponsor. The Convertible Promissory Note No.1 bears no interest and is repayable in full upon the consummation of the Company's business combination. It is convertible at the Sponsor's election upon the consummation of the Company's business combination. Upon such election, the note will convert, at a price of $ 10.00 per unit, into units identical to the private placement units issued in connection with the Company's Initial Public Offering.

 On each of October 10, 2023, November 8, 2023 and December 14, 2023, the Company issued an unsecured promissory note (each is called "October 2023 Convertible Note", "November 2023 Convertible Note" and "December 2023 Convertible Note", respectively, collectively with September 2023 Convertible Note were called "Convertible Promissory Notes") amounting to $ 100,000, $ 190,112 and $ 100,000, respectively, for an aggregated of $ 390,112, to the Company's CFO. The Convertible Promissory Notes bear no interest and are repayable in full upon the consummation of the Company's Business Combination. They are convertible at the Sponsor's or CFO's election upon the consummation of the Company's Business Combination. Upon such election, the notes will convert, at a price of $ 10.00 per unit, into units identical to the private placement units issued in connection with the Company's Initial Public Offering.

 From January 1, 2024 to December 31, 2024,
the Company issued five unsecured promissory notes (together with the convertible promissory notes as described above, were called "Convertible
Promissory Notes") amounting to $100,000, $100,000, $100,000, $70,000 and $81,000, respectively, for an aggregated of $451,000,
to the Company's CFO. The Convertible Promissory Notes bear no interest and are repayable in full upon the consummation of the Company's
Business Combination. They are convertible at the CFO's election upon the consummation of the Company's Business Combination.
Upon such election, the notes will convert, at a price of $10.00 per unit, into units identical to the private placement units issued
in connection with the Company's Initial Public Offering.

 F- 17

 As of December 31, 2024, the Company has
borrowed $ 851,112 under the Convertible Promissory Notes, of which $ 841,112 was issued to the Company's CFO, and $ 10,000 was issued
to the Sponsor.

 As of December 31, 2023, the Company has
borrowed $ 400,112 under the Convertible Promissory Notes, of which $ 390,112 was issued to the Company's CFO, and $ 10,000 was issued
to the Sponsor.

 Working Capital Loans

 In order to finance transaction costs in connection
with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor, or the Company's officers and directors
may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). Such Working Capital Loans
would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest,
or, at the lender's discretion, up to $ 500,000 of notes may be converted upon consummation of a Business Combination into additional
Private Units at a price of $ 10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of
proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to
repay the Working Capital Loans. As of December 31, 2024 and 2023, the Company borrowed $ 241,112 and $ 90,112, respectively, which
was included in convertible promissory note – related party.

 Office Space Provided by Sponsor

 The Company currently maintain executive offices at 5186 Carroll Canyon Rd, San Diego, CA 92121. Such space was provided to the Company free of charge by the Sponsor.

 NOTE 6. DUE TO THIRD PARTY

 From July 2024 to December 2024, the Company
borrowed an aggregated amount of $ 775,000
from Tianji and its subsidiaries. These amounts are unsecured, non-interest bearing and due on demand. As of December 31, 2024, the amounts due to third
party was $ 775,000.

 NOTE 7. PROMISSORY NOTE - THIRD PARTY

 On August 5, 2024, the Company issued an unsecured
promissory note, in an amount of $ 300,000 to an unrelated third party, which are used as the extension fee and/or working capital. The
unpaid principal balance of this note bears an annual interest rate of nine point one two seven percent ( 9.127 %) per annum. The note will
be due two months after executed. On August 6, 2024, the Company received the $300,000 in full under such note. On September 10, 2024,
and September 27, 2024, the Company repaid $100,000 and $150,000, respectively, to the payee, leaving $50,000 in principal unpaid as of
December 31, 2024. On October 5, 2024, the principal of $50,000 was due and will be paid on demand. Up to the date the financial statements
were issued, the principal of $50,000 remained unpaid and past due.

 For the year ended December 31, 2024, the Company
recorded $ 4,664 in interest expenses under the promissory note - third party. As of December 31, 2024, the total outstanding under the
promissory note- third party was $ 54,664.

 F- 18

 NOTE 8. COMMITMENTS AND CONTINGENCIES

 Registration Rights

 The initial shareholders and their permitted transferees can demand that the Company register the founder shares, the private units and the underlying private shares and private warrants, and the units issuable upon conversion of working capital loans and the underlying ordinary shares, warrants and rights, pursuant to a Registration Rights Agreement signed on August 9, 2022. The holders of such securities are entitled to demand that the Company register these securities at any time after consummation of a Business Combination. Notwithstanding anything to the contrary, any holder that is affiliated with an underwriter participating in the Company's IPO may only make a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement. In addition, the holders have certain "piggy-back" registration rights on registration statements filed after our consummation of a business combination; provided that any holder that is affiliated with an underwriter participating in the Company's IPO may participate in a "piggy-back" registration only during the seven-year period beginning on the effective date of the registration statement.

 The underwriters purchased the 892,855 of additional Units to cover over-allotments, less the underwriting discounts and commissions.

 The underwriters were entitled to a cash underwriting
discount of one percent ( 1.00 %) of the gross proceeds of the Offering, or $ 739,286 as the underwriters' over-allotment is partially
exercised. The underwriters are also entitled to a deferred fee of three point five percent ( 3.50 %) of the gross proceeds of the Offering,
or $ 2,587,499 as the underwriters' over-allotment is partially exercised upon closing of the Business Combination. On March 4,
2024, the Company and the underwriters, entered into a satisfaction and discharge of indebtedness pursuant to underwriting agreement dated
August 9, 2022 (the "Satisfaction and Discharge Agreement"), pursuant to which, the underwriter agrees to revise the
deferred underwriting fee of $2,587,499, to (1) $ 750,000 in cash on the date of the closing of the initial business combination (the "Closing")
and (2) 200,000 of registered and unrestricted shares of the Company, shall be issued and delivered to the underwriter at the Closing.
The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to
the terms of the underwriting agreement. The Company evaluated the Satisfaction and Discharge Agreement and concluded that the share settlement
portion of the Satisfaction and Discharge Agreement is representative of a share-based payment transaction in which the Company is acquiring
services to be used within the Company's operations and upon settlement agreeing to issue ordinary shares. In this case, the share
settlement portion of the Satisfaction and Discharge Agreement is within the scope of FASB ASC Topic 718, "Compensation-Stock Compensation"
("ASC 718"). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon
the Satisfaction and Discharge Agreement executed date (the "Grant Date"). The Company used the public trading price of Class
A ordinary shares at Grant Date to value the fair value of the Granted Shares. The fair value of the 200,000 Granted Shares was $ 2,216,000
in total, or $11.08 per share. The Satisfaction and Discharge Agreement was executed on March 4, 2024, the underwriter has provided
service to the Company prior to closing of the IPO and the Company has recorded $ 1,837,499 deferred liability for the share settlement
portion of the Satisfaction and Discharge Agreement at the closing of the IPO. The fair value of Granted Shares in excess of the liability
settled, in the amount of $ 378,501, as a result of the Satisfaction and Discharge Agreement was recorded as loss on the modification of
deferred underwriting commission in the accompanying statements of operations.

 In addition, the Company paid the representative of the underwriters, at closing of the Initial Public Offering, 1.00 % of the of the IPO shares in the Company's ordinary shares or 73,929 ordinary shares as the underwriters' over-allotment was partially exercised.

 Right of First Refusal

 For a period beginning on the closing of the Company's
IPO and ending 6 months from the closing of a business combination, the Company have granted EF Hutton, division of Benchmark Investments,
LLC a right of first refusal to act as sole investment banker, sole book running manager and/or sole placement agent for any and all future
private or public equity, equity-linked, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(g)(6)(A),
such right of first refusal shall not have a duration of more than three years from the commencement of sales in the Company's IPO.

 F- 19

 NOTE
 9. STOCKHOLDERS' DEFICIT

 Ordinary Shares — The
Company is authorized to issue 500,000,000
ordinary shares of with a par value of $ 0.0001
per share. Holders of the Company's Ordinary shares are entitled
to one vote for each share.

 Prior to the offering, the Company issued 1,437,500 ordinary shares to our initial shareholders. On October 24, 2021, the Company declared a share dividend of 0.50 shares for each outstanding share, resulting in an aggregate of 2,156,250 founder shares being issued. The aggregate purchase price for the founder shares was $ 25,000.

 On July 1, 2022, the sponsor surrendered an aggregate of 287,500 founder shares for no consideration, which surrender was effective retroactively, resulting in 1,868,750 shares being outstanding. On August 12, 2022, as a result of the partial exercise of the Representative's Over-Allotment Option, an aggregate of 20,536 founder shares were further forfeited to the Company, which surrender was effective retroactively and resulting in 1,848,214 shares being outstanding and held by Sponsor.

 As of December 31, 2024 and 2023, there were
 2,295,893 ordinary shares issued and outstanding, excluding 2,224,131 and 5,127,282 ordinary shares subject to possible redemption, respectively.

 Warrants — Public Warrants may only be
exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The warrants will become exercisable
 days after the completion of a Business Combination. No Warrants will be
exercisable for cash unless the Company has an effective and current registration statement covering the ordinary share issuable upon
exercise of the Warrants and a current prospectus relating to such ordinary share. Notwithstanding the foregoing, if a registration statement
covering the ordinary share issuable upon the exercise of the Warrants is not effective within 90
days from the consummation of a Business Combination, the holders
may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain
an effective registration statement, exercise the Warrants on a cashless basis pursuant to an available exemption from registration under
the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Warrants on a cashless
basis. The Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

 The Company may call the Warrants for redemption, in whole and not in part, at a price of $ 0.01 per warrant:

 at any time while the Warrants are exercisable,

 upon not less than 30 days' prior written notice of redemption to each Warrant holder,

 if, and only if, the reported last sale price of the ordinary share equals or exceeds $ 18 per share, for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the notice of redemption to Warrant holders, and

 if, and only if, there is a current registration statement in effect with respect to the ordinary share underlying such warrants at the time of redemption and for the entire 30 -day trading period referred to above and continuing each day thereafter until the date of redemption.

 The private warrants (including the ordinary shares issuable upon exercise of the private warrants) will not be transferable, assignable or salable until 30 days after the completion of our Business Combination and they will not be redeemable by the Company so long as they are held by the initial shareholders or their permitted transferees. The initial shareholders, or their permitted transferees, have the option to exercise the private warrants on a cashless basis.

 If the Company calls the Warrants for redemption,
management will have the option to require all holders that wish to exercise the Warrants to do so on a "cashless basis,"
as described in the warrant agreement. The exercise price and number of ordinary share issuable upon exercise of the warrants may be
adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization,
merger, or consolidation. However, the warrants will not be adjusted for issuances of ordinary share at a price below its exercise price.
Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business
Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not
receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held
outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

 F- 20

 The Company accounts for 7,766,605 warrants issued in connection with the Initial Public Offering (comprised of 7,392,855 Public Warrants and 373,750 Private Warrants) (the "Warrants") in accordance with the guidance contained in ASC 815-40 Derivatives and Hedging - Contracts in Entity's Own Equity ("ASC 815") under which the Warrants meet the criteria for equity treatment and was recorded as a component of additional paid-in capital at the time of issuance.

 Rights — Each
holder of a right will receive one-eighth (1/8) of one ordinary share upon consummation of a Business Combination, even if the
holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued
upon exchange of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its
additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the unit
purchase price paid for by investors in the IPO. If the Company enters into a definitive agreement for a Business Combination in
which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the
same per share consideration the holders of the ordinary share will receive in the transaction on an as- converted into ordinary
share basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/8 share underlying
each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable
(except to the extent held by affiliates of the Company).

 Additionally, in no event will the Company be required
to net cash settle the rights. If the Company is unable to complete a Business Combination within the Combination Period and the Company
liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor
will they receive any distribution from the Company's assets held outside of the Trust Account with respect to such rights. Accordingly,
the rights may expire worthless.

 NOTE 10. SUBSEQUENT EVENTS

 On January 26, 2025, the Company entered into a Merger Agreement by
and between the Company, Purchaser, Merger Sub, and Tianji, as described in Note 1.

 From January 2025 to March 2025, the Company
borrowed an aggregated amount of $ 200,000
from Tianji and its subsidiaries. These amounts are unsecured, non-interest bearing and due on demand. Up to the date the financial statements were
issued, the Company received $ 975,000
in total, from Tianji and its subsidiaries.

 F- 21

 Exhibit No.

 Description

 3.1

 Third Amended and Restated Memorandum and Articles of Association of Embrace Change Acquisition Corp. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 15, 2024)

 4.1

 Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-1/A (file No. 333-265184) filed with the SEC on July 25, 2022)

 4.2

 Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-1/A (file No. 333-258221) filed with the SEC on May 13, 2022)

 4.3

 Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1/A (file No. 333-258221) filed with the SEC on May 13, 2022)

 4.4

 Specimen Right Certificate (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form S-1/A (file No. 333-265184) filed with the SEC on July 25, 2022)

 4.5

 Warrant Agreement, dated August 9, 2022, by and between the Company and Continental Stock Transfer & Trust Company, LLC (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 4.6

 Rights Agreement, dated August 9, 2022, by and between the Company and Continental Stock Transfer & Trust Company, LLC (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 4.7*

 Description of Securities

 10.1

 Form of Letter Agreements, dated August 9, 2022, by and among the Company and its officers, directors, the Sponsor and certain other holders (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 10.2

 Investment Management Trust Agreement, dated August 9, 2022, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 10.3

 Amendment to the Investment Management Trust Agreement, dated as of August 9, 2023, between Embrace Change Acquisition Corp. and Continental Stock Transfer & Trust Company dated August 9, 2022 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 10, 2023)

 10.4

 Registration Rights Agreement, dated August 9, 2022, by and among the Company and certain security holders of the Company (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 10.5

 Form of Indemnity Agreements, dated August 9, 2022, by and among the Company and each of the officers and directors of the Company (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 10.6

 Unit Subscription Agreement, dated August 9, 2022, by and between the Company and Sponsor (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 12, 2022)

 10.7

 Promissory Note issued by the Company to the Sponsor on September 8, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on September 11, 2023)

 10.8

 Promissory Note issued by the Company to Zheng Yuan on October 12, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on October 13, 2023)

 10.9

 Promissory Note issued by the Company to Zheng Yuan on November 13, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on November 14, 2023)

 10.10

 Promissory Note issued by the Company to Zheng Yuan on December 15, 2023 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on December 18, 2023)

 10.11

 Promissory Note issued by the Company to Zheng Yuan on January 17, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on January 19, 2024)

 10.12

 Promissory Note issued by the Company to Zheng Yuan on February 16, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on February 20, 2024)

 10.13

 Satisfaction and Discharge of Indebtedness Pursuant to Underwriting Agreement dated August 9, 2022, dated March 4, 2024, between the Company and EF Hutton (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on March 14, 2024)

 10.14

 Promissory Note issued by the Company to Zheng Yuan on March 13, 2024 (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on March 14, 2024)

 10.15

 Promissory Note issued by the Company to Zheng Yuan on March 21, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on March 25, 2024).

 10.16

 Promissory Note issued by the Company to Zheng Yuan on May 7, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 10, 2024).

 10.17

 Promissory Note issued by the Company on August 5, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 6, 2024).

 10.18

 Amendment No. 2 to the Investment Management Trust Agreement, dated as of August 12, 2024, between Embrace Change Acquisition Corp. and Continental Stock Transfer & Trust Company dated August 9, 2022, as amended (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on August 15, 2024)

 Code of Ethics (incorporated by reference to Exhibit 14 to the Registration Statement on Form S-1/A filed with the Securities & Exchange Commission on July 25, 2022)

 31.1*

 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to § 302 of the Sarbanes-Oxley Act of 2002

 31.2*

 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to § 302 of the Sarbanes-Oxley Act of 2002

 32*

 Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002

 97.1

 Clawback Policy (incorporated by reference to Exhibit 97.1 to the Annual Report on Form 10-K filed with the Securities & Exchange Commission on July 26, 2024)

 99.1

 Audit Committee Charter (incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-1/A filed with the Securities & Exchange Commission on July 25, 2022)

 99.2

 Nominating Committee Charter (incorporated by reference to Exhibit 99.2 to the Registration Statement on Form S-1/A filed with the Securities & Exchange Commission on July 25, 2022)

 99.3

 Compensation Committee Charter (incorporated by reference to Exhibit 99.3 to the Registration Statement on Form S-1/A filed with the Securities & Exchange Commission on July 25, 2022)

 101.INS*

 101.SCH*

 101.CAL*

 101.DEF*

 101.LAB*

 101.PRE*

 104*

 *

 Filed herewith.

 ITEM 16.

 FORM 10-K SUMMARY

 Not Applicable.

 SIGNATURES

 Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 Embrace Change Acquisition Corp.

 Dated: March 11, 2025

 By:

 /s/ Jingyu Wang

 Name:

 Jingyu Wang

 Title:

 Chief Executive Officer

 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 Signature

 Title

 Date

 /s/ Jingyu Wang

 Chief Executive Officer. President and Director

 Jingyu Wang

 (Principal Executive Officer)

 /s/ Zheng Yuan

 Chief Financial Officer

 Zheng Yuan

 (Principal Accounting and Financial Officer)

 /s/ Jiangping (Gary) Xiao

 Director

 Jiangping (Gary) Xiao

 /s/ Hang Zhou

 Director

 Hang Zhou

 /s/ Mo Zhou

 Director

 Mo Zhou